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1. PUBLIC HEALTH STATEMENT
This Statement was prepared to give you information about Stoddard solvent and toemphasize the human health effects
that may result from exposure to it. The Environmental Protection Agency (EPA) has identified 1,397 sites on its
“National Priorities List” (NPL).  Stoddard solvent has been found in at least seven of these sites. However, we do not
know how many of the 1,397 NPL sites have been evaluated for Stoddard solvent. As EPA evaluates more sites, the
number of sites at which Stoddard solvent is found may change.  This information is important for you to know because
Stoddard solvent may cause harmful health effects and because these sites are potential or actual sources of human
exposure to Stoddard solvent.
When a chemical is released from a large area, such as an industrial plant, or from a container, such as a drum or
bottle, it enters the environment as a chemical emission. This emission, which is also called a release, does not always
lead to exposure. You can be exposed to a chemical only when you come into contact with the chemical. You may be
exposed to it in the environment by breathing, eating, or drinking substances containing the chemical or by skin contact
with it.
If you are exposed to a hazardous chemical such as Stoddard solvent, several factors will determine whether harmful
health effects will occur and what the type and severity of those health effects will be. These factors include the dose
(how much), the duration (how long), the route or pathway by which you are exposed (breathing, eating, drinking, or
skin contact), the other chemicals to which you are exposed, and your individual characteristics such as age, sex,
nutritional status, family traits, life-style, and state of health.
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1.1 WHAT IS STODDARD SOLVENT?
Stoddard solvent is a widely used, man-made organic solvent that comes from the refining of crude oil. It is a
petroleum mixture made from distilled alkanes, cycloalkanes (naphthenes), and aromatic compounds. The chemicals in
Stoddard solvent are similar to those in white spirits, which are also discussed in this profile. Stoddard solvent is
commonly referred to as dry cleaning safety solvent, naphtha safety solvent, petroleum solvent, PD-680, varnoline, and
spotting naphtha. It also goes by the registered trade names Texsolve S and Varsol 1. Stoddard solvent is used as a
paint thinner, as a solvent in some types of photocopier toners, in some types of printing inks, in some adhesives, as a
dry cleaning sollvent, and as a general cleaner and degreaser. It is produced and used as a colorless, flammable liquid
but will turn into a vapor (gas) at temperatures ranging from 150-200°C. Stoddard solvent smells and tastes like
kerosene. You can smell it when the level in the air is about 0.34 parts of Stoddard solvent in a million parts of air
(ppm) or 2 milligrams of Stoddard solvent per cubic meter of air (mg/m3). See Chapters 3 and 4 for more information
on the physical and chemical properties of Stoddard solvent and how it is produced and used.
1.2 WHAT HAPPENS TO STODDARD SOLVENT WHEN IT ENTERS THE
      ENVIRONMENT?
Stoddard solvent is a mixture of many chemicals. Some of these evaporate into the air when Stoddard solvent spills
onto soils or surface waters. These chemicals may be broken down by sunlight or by other chemicals in the air. Also,
some of these chemicals may sorb (attach) to organic matter. Stoddard solvent itself does not dissolve well in water,
but some of the chemicals in it do dissolve when it spills on surface water or when it leaks from underground storage
tanks. Some of the chemicals in Stoddard solvent can attach to particles soil or water and, in water, may sink down to
the sediment. In water, soil, or sediment, microorganisms may break down the chemicals (a process known as
biodegradation).  Although some of the chemicals that make up Stoddard solvent can attach to organic matter  in the
soil, if a large amount of Stoddard solvent contaminates the soil, it will move through the soil into groundwater. It is
not known whether Stoddard solvent will accumulate in plants
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or animals living in contaminated soil or water, or in animals eating contaminated plants or sediments. However, some
of the chemicals that make up the Stoddard solvent mixture might accumulate in these situations, depending upon the
type of chemical. Generally, smaller alkanes do not tend to bioaccumulate, while aromatics and larger alkanes,
including some cycloalkanes, tend to bioaccumulate. See Chapter 5 for more information on what happens to Stoddard
solvent when it enters the environment.
1.3 HOW MIGHT I BE EXPOSED TO STODDARD SOLVENT?
You are most likely to be exposed to Stoddard solvent if you use a product, such as paint or a paint thinner, that
contains it and the vapors get in your lungs or eyes. If you work in an industry that uses or produces dry cleaning fluid,
paints, coatings, waxes, or equipment cleaning fluid with Stoddard solvent in it, you may breathe in some of the
components of Stoddard solvent that evaporate into the air. You may be exposed to Stoddard solvent if you breathe air
that contains Stoddard solvent after it has entered the atmosphere from a dry cleaning plant or spilled or leaked onto
soils or surface water. When it is spilled, the different components that make up Stoddard solvent will react differently
in the different media of the environment (for example, in soil, water, or air). So, if you become exposed, you are no
longer being exposed to a single compound called Stoddard solvent but rather to its components. You would only
breathe the components that evaporate into the air. If Stoddard solvent has contaminated groundwater, you may be
exposed if you drink this water or use it for bathing or washing. If you use products that contain Stoddard solvent and
do not wear protective clothing, you may be exposed if it gets on your skin.
Humans may be exposed to Stoddard solvent near hazardous waste sites, but it is not known how many are being
exposed. It is unclear what routes of exposure are most significant at hazardous waste sites. It is likely that you might
be exposed to Stoddard solvent near a hazardous waste site by breathing it in the air. Although some compounds in
Stoddard solvent evaporate quickly, you may be continually exposed near hazardous waste sites if the material is
leaking from buried or above-ground drums or is slowly moving through the soil
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and seeping through the walls of the basement of a building. If Stoddard solvent is buried in leaky drums at hazardous
waste sites, you may also be exposed if you touch contaminated soil or if you drink contaminated groundwater.
For more information on how humans can be exposed to Stoddard solvent, see Chapter 5.
1.4 HOW CAN STODDARD SOLVENT ENTER AND LEAVE MY BODY?
Stoddard solvent can enter your body if you breathe air containing it. When you breathe in Stoddard solvent, it can
quickly enter your bloodstream. The chemical components that make up Stoddard solvent will then be absorbed by
different tissues in your body. It may also enter the brain, and a large portion may be stored in body fat. Stoddard
solvent can also enter your body if you come into contact with water that is contaminated with it. However, we do not
know where the components of Stoddard solvent go once in the body after contact with your skin or after drinking
contaminated groundwater. Animal studies have shown that these components can enter tissues and the brain, as is the
case with Stoddard solvent when it is breathed in, but no human studies have been located to verify this. Components
of white spirits have been found, however, in human blood and body fat after people breathed it. We also do not know
exactly how the mixture or its components leave the body and how quickly this happens. Some components or
breakdown products probably leave in the breath and urine within a few days after exposure. For more information on
how Stoddard solvent enters and leaves the human body, see Chapter 2.
1.5 HOW CAN STODDARD SOLVENT AFFECT MY HEALTH?
Most of the information on how Stoddard solvent affects human health comes from studies where exposure is through
breathing, with fewer studies available on exposure to the eyes and skin. When Stoddard solvent is in the air, it can
cause eye, skin, or throat irritation. If you were to breath in air containing Stoddard solvent, it could affect your
nervous system and might cause dizziness or headaches. Another way that it can affect your nervous system is by
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causing a prolonged reaction time. There are few studies of the long-term effects of exposure to Stoddard solvent alone
in humans. In experiments with rats, cats, and dogs (to suggest what may happen in humans), seizures were reported
after they breathed in large amounts for several hours. Stoddard solvent can also cause bronchitis in guinea pigs when
they breathe it.  However, Stoddard solvent has not had these effects in the few known cases of human exposure.
Studies with rats show that Stoddard solvent may also cause kidney damage, but only in males. This is because of its
interaction with a protein that male rats produce but which is not found in female rats. Humans do not produce this
protein either, so it is unlikely that people would experience kidney damage. For the following effects in humans or
animals, either there were no studies or the available studies did not associate the effect with exposure to Stoddard
solvent: birth defects, reproductive effects (infertility), and immunological or lymphoreticular effects.
Very few studies have been located that study the carcinogenic (cancer-causing) effects of Stoddard solvent in humans
and animals. Stoddard solvent has not been classified by the Department of Health and Human Services (DHHS),
EPA, or the International Agency for Research on Cancer (IARC) (or by any other national or international agencies)
for carcinogenic effects in any exposure situation.
Little is known about the health effects of Stoddard solvent in humans or animals when it is ingested (swallowed); no
studies have been found. For more information on the health effects of Stoddard solvent in humans and animals, see
Chapter 2.
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1.6   IS THERE A MEDICAL TEST TO DETERMINE WHETHER I HAVE BEEN
        EXPOSED TO STODDARD SOLVENT?
There is no routinely used test to show whether you have been exposed to Stoddard solvent.  However, Stoddard
solvent is a mixture of many chemicals, and for most of them there are analytical methods to determine whether
exposure has occurred. These chemicals can be detected in your breath, blood, urine, and fat. However, the tests cannot
tell you if you have been exposed to the specific mixture of chemicals found in Stoddard solvent. These methods also
cannot tell you whether you will have any health effects. It is unclear how long after exposure to Stoddard solvent a
test would be useful. Because Stoddard solvent can be stored in fat, any resulting health effects may continue for a few
days after exposure. See Chapters 2 and 6 for more information on the methods available to find Stoddard solvent in
human tissue.
1.7 WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO PROTECT HUMAN
      HEALTH?
The government has developed regulations and guidelines for Stoddard solvent that are designed to protect the public
from potential harmful health effects. Several states have set their own regulations or guidelines for Stoddard solvent
concentrations in water and in ambient (surrounding) air. The Occupational Safety and Health Administration (OSHA)
regulates levels of hazardous material in the workplace. The maximum allowable amount of Stoddard solvent in
workroom air during an S-hour workday, 40-hour workweek, is 2,900 mg/m3 or 500 ppm. The National Institute for
Occupational Safety and Health (NIOSH) recommends a limit of 350 mg/m3 or 60 ppm for workroom air for an 8-hour
exposure.
The Department of Transportation has identified Stoddard solvent as a hazardous substance and regulates its
packaging, shipping, and transportation. Some states have transportation regulations for Stoddard solvent. Other
regulations and guidelines that have been set for Stoddard solvent can be found in Table 7-l.
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1.8 WHERE CAN I GET MORE INFORMATION?
If you have any more questions or concerns, please contact your community or state health or environmental quality
department or:
Agency for Toxic Substances and Disease Registry
Division of Toxicology
1600 Clifton Road NE, E-29
Atlanta, Georgia 30333
This agency can also provide you with information on the location of the nearest occupational and environmental






The primary purpose of this chapter is to provide public health officials, physicians, toxicologists, and
other interested individuals and groups with an overall perspective of the toxicology of Stoddard
solvent and a depiction of significant exposure levels associated with various adverse health effects. It
contains descriptions and evaluations of studies and presents levels of significant exposure for
Stoddard solvent based on toxicological studies and epidemiological investigations.
Stoddard solvent is a mixture of numerous hydrocarbons derived by refining crude oil. It is a
petroleum distillate with a boiling range of 154-202°C and a flashpoint of 38-60°C. The hydrocarbon
chain length ranges from C7 to C12 although a form of Stoddard solvent called 140 flash contains C5
and C6 hydrocarbons as well. The mixture consists of three major groups of components: linear and
branched alkanes, also known as paraffins (30-50% of the total mixture); cycloalkanes, also called
cycloparaffins or naphthenes (not to be confused with naphthalenes which are bicyclic aromatics)
(30-40%), and aromatic hydrocarbons (l0-20%). A complete list of the individual components of
Stoddard solvent is not available (Air Force 1989b); however, some possible components and common hydrocarbon
classes are presented in Chapter 3. Data are available on the health effects of the various components of Stoddard
solvent, but discussion of individual constituents is beyond the scope of the profile. Exposure to Stoddard solvent and
white spirits, a somewhat synonymous substance, is discussed in this profile.
Stoddard solvent is also considered to be a form of mineral spirits, white spirits, and naphtha;
however, not all forms of mineral spirits, white spirits, or naphtha are considered to be Stoddard
solvent. Other petroleum distillate mixtures are also the subject of ATSDR toxicological profiles,
including gasoline (ATSDR 1993). Gasoline differs from Stoddard solvent by having more smallerchained
hydrocarbons (C5-C12). Kerosene, a fuel oil, has longer-chained hydrocarbons  (C10-C16), and more aromatic
components (30-40%) than Stoddard solvent (l0-20%). Stoddard solvent contains few if any alcohols, glycols, or
ketones. Stoddard solvent is not expected to contain hexane or polycyclic aromatic hydrocarbons, substances that are
also known to have a toxic potential.
STODDARD SOLVENT 10
2. HEALTH EFFECTS
Within the aromatic hydrocarbon group, there are several substances that are known to be toxic,
including substituted benzenes, naphthalenes, and substituted toluenes. The contributions of benzenes,
naphthalenes, and toluenes are slight since each contributes less than 1% of the total composition of
the Stoddard solvent mixture. However, the toxicity of the mixture is probably not governed by any
single component. The toxicity of the mixture depends on the interactions of all the components.
Some components, when found together, may act additively or synergistically to enhance toxic effects.  Others
components may be antagonistic in combination, thus diminishing toxic effects. It cannot always be predicted how a
mixture will behave based on the toxicity of its individual components.  However, the toxic characteristics of the
individual components may be an indicator of the potential toxicological responses of the mixture.
2.2 DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE
To help public health professionals address the needs of persons living or working near hazardous
waste sites, the information in this section is organized first by route of exposure--inhalation, oral, and
dermal--and then by health effect--death, systemic, immunological, neurological, developmental,
reproductive, genotoxic, and carcinogenic effects. These data are discussed in terms of three exposure
periods--acute (14 days or less), intermediate (15-364 days), and chronic (365 days or more).
Levels of significant exposure for each route and duration are presented in tables and illustrated in
figures. The points in the figures showing no-observed-adverse-effect levels (NOAELs) or lowest-observed-
adverse-effect levels (LOAELs) reflect the actual doses (levels of exposure) used in the studies. LOAELs 
have been classified into “less serious” or “serious” effects. These distinctions are intended to help the users of 
the document identify the levels of exposure at which adverse health effects start to appear. They should also 
help to determine  whether or not the effects vary with dose and/or duration, and place into perspective 
the possible significance of these effects to human health.
The significance of the exposure levels shown in the tables and figures may differ depending on the
user’s perspective. For example, physicians concerned with the interpretation of clinical findings in
exposed persons may be interested in levels of exposure associated with “serious” effects. Public
health officials and project managers concerned with appropriate actions to take at hazardous waste
sites may want information on levels of exposure associated with more subtle effects in humans or
animals (LOAEL) or exposure levels below which no adverse effects (NOAEL) have been observed.
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Estimates of levels posing minimal risk to humans (Minimal Risk Levels, MRLs) may be of interest to
health professionals and citizens alike.
Estimates of exposure levels posing minimal risk to humans (MRLs) have been made, where data were believed
reliable, for the most sensitive noncancer effect for each exposure duration. MRLs include adjustments to reflect
human variability and extrapolation of data from laboratory animals to humans.
Although methods have been established to derive these levels (Barnes and Dourson 1988; EPA 1990)
uncertainties are associated with these techniques. Furthermore, ATSDR acknowledges additional
uncertainties inherent in the application of the procedures to derive less than lifetime MRLs. As an
example, acute inhalation MRLs may not be protective for health effects that are delayed in
development or are acquired following repeated acute insults, such as hypersensitivity reactions,
asthma, or chronic bronchitis As these kinds of health effects data become available and methods to
assess levels of significant human exposure improve, these MRLs will be revised.
2.2.1 Inhalation Exposure
A few studies are available in which humans were acutely exposed in the laboratory to measured
levels of Stoddard solvent or white spirits in the air. No studies are available regarding health effects
in humans after intermediate-duration inhalation exposure to Stoddard solvent. Workers chronically
exposed to combinations of solvents, including Stoddard solvent, have been studied.
There are only a few studies showing acute toxic effects in animals (API 1987a; Carpenter et al.
1975a, 1975b; Riley 1984). The animals were exposed to completely vaporized Stoddard solvent, but
in real life human inhalation exposures might be primarily to the more volatile components. Data
from acute studies in cats, dogs, mice, and rats and from intermediate studies in guinea pigs, rats, and
dogs that demonstrate toxicity are shown in Table 2-l and Figure 2-l. One of the intermediate studies
(Rector et al. 1966) used a mixture of chemicals called mineral spirits, but the authors stated that this
particular mixture was similar to Stoddard solvent, so the information is included below. Other studies
testing different formulations of mineral spirits are not included. No studies are available regarding
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2.2.1.1  Death
The only available study in humans regarding death following inhalation exposure is a retrospective
cohort study on workers at an aircraft maintenance facility exposed to very low levels of Stoddard
solvent as well as numerous other chemicals for at least 1 year (Spirtas et al. 1991). An exposure
index was developed by evaluating patterns of use that indicated comparative differences in exposure
to various chemicals based on occupation. However, exposures could not be quantitated from these
methods. The study did not show a statistically significant increase in mortality.
Rats that were exposed for 8 hours to 8,200 mg/m3 of completely vaporized Stoddard solvent (48%
alkames, 26% monocycloalkanes, 12% dicycloalkanes, 14% aromatics) had no compound-related
mortality when observed for up to 10 days (Carpenter et al. 1975a, 1975b). However, in a study with
mixed breed cats, limited by the fact that there were only four, all animals died within 2.5-7.5 hours
of an initiation exposure of 10,000 mg/m3 (Carpenter et al. 1975a, 1975b). Rats, rabbits, dogs, and
monkeys had no mortality immediately following continuous exposure to 1,271 mg/m3 of vaporized
mineral spirits (80-86% alkanes, 13-19% aromatics) for 90 days (Rector et al. 1966). However, the
data for rabbits, dogs, and monkeys are limited by the use of three animals or less. Guinea pigs,
however, were more sensitive, and 4 of 15 died after continuous exposure to 363 mg/m3; no
information on time of death was provided. The remaining test animals were sacrificed at the end of
the exposure period. There were no adverse hematological, biochemical, or pathological findings that
could account for the deaths of the guinea pigs. Many of the animals had liver parasites and
occasionally pulmonary congestion, which indicates that poor health, rather than chemical exposure,
could have contributed to the deaths. However, the worms and congestion were also present in the
other tested species, which did not exhibit mortality. The study authors could not otherwise account
for the species differences in mortality. When this study was repeated (continuous exposure to
892 mg/m3 of vaporized mineral spirits [20% aromatics] for 90 days), there were deaths of
13/30 guinea pigs of the Hartley strain and 20/30 of the NMRI strain (Jenkins et al. 19713. More
males than females died. In another test, male Hartley guinea pigs with a high ascorbic acid diet
survived better (2/15 deaths) than those on a low ascorbic acid diet (10/15 deaths). No deaths
occurred in guinea pigs or any of the other species after repeated exposures (6 weeks, 5 days/week,
8 hours/day) to 1,353 mg/m3 (Rector et al. 1966). It is possible that the difference in guinea pig
mortality between the two protocols was due to recovery time during the intermittent exposures. Rats
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exposed to white spirit (20% aromatics) 6 hours/day, 5 days/week for 6 months showed no compound related mortality
at doses up to 4,580 mg/m3 (Ostergaard et al. 1993). The reason for the apparent species difference in susceptibility to
the toxic effects of Stoddard solvent is unknown. The LOAELs for death for intermediate exposure are recorded in
Table 2- 1 and plotted in Figure 2- 1.
2.2.1.2 Systemic Effects
No studies were located regarding dermal effects in humans or animals after inhalation exposure to
Stoddard solvent. Ocular effects that occurred after inhalation exposure to Stoddard solvent have
resulted from direct contact with the eyes and are discussed in Section 2.2.3.
For other systemic effects, the highest NOAEL and all reliable LOAEL values for each species, end
point, and duration category are recorded in Table 2-l and plotted in Figure 2-l.
Respiratory Effects. In an experimental study, there was no change in respiratory rate in 10 human
males who were exposed to 2,400 mg/m3 (457 ppm) of completely vaporized Stoddard solvent for
30 minutes (Hastings et al. 1984). Men exposed in an experimental setting to up to 2,500 mg/m3
(476 ppm) of vaporized white spirits (83% aliphatic and 17% aromatic components) for 30 minutes
had no compound-related changes in oxygen uptake or alveolar ventilation measured at rest or during
exercise (Astrand et al. 1975). In a retrospective cohort study, house painters breathed paint solvents
containing Stoddard solvent for 4-42 years. Precise exposure levels were not available. Each painter
was given a health interview and a traditional medical examination 15 hours after exposure. They had
no decrease in lung vital capacity or forced expiratory volume, as compared to workers in other
industries (Hane et al. 1977). Throat irritation was noted in one out of six volunteers exposed to
2,700 mg/m3 completely vaporized Stoddard solvent, 15 minutes/day for 3 days (Carpenter et al.
1975a, 1975b). Recovery from this effect was noted 15 minutes post-exposure.
In an acute exposure study, mice exposed to 10,000 mg/m3 (1,905 ppm) of completely vaporized
Stoddard solvent for 1 minute had a 50% reduction in respiratory rate, which was not seen at
4,400 mg/m3 (Carpenter et al. 1975a, 1975b). Recovery tests were not performed. Exposure of rats to
around their nostrils, while 4,600 mg/m3 completely vaporized Stoddard solvent for 8 hours 
produced bloody exudate no effects were observed in animals exposed to 2,400 mg/m3 ed to 214
(Carpenter et al. 1975a, 1975b). Rats exposmg/m3 of vaporized white spirits (61% alkanes, 20% cycloalkanes,
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19% aromatics) for 4 hours/day for 4 days had irritation of the upper respiratory tract lining as
evidenced by inflammatory cell infiltrate of the nasal cavity, trachea, and larynx. Other
histopathological changes included loss of cilia, hyperplasia of basal cells, and squamous metaplasia 
in the trachea and nasal cavity (Riley et al. 1984). According to the authors, these histopathological
changes are not indicative of lung injury, but represent insult to the upper respiratory tract. This study
was limited because only one dose was tested.
In an intermediate exposure study rats, rabbits, guinea pigs, dogs, and monkeys that were exposed to
I,27 1 mg/m3 of vaporized mineral spirits with a composition similar to Stoddard solvent continuously
for 90 days had congestion of the lungs, bronchitis, and mixed inflammatory cell infiltration (Rector et
al. 1966). However, some control animals had mild congestion on gross examination, but histopathology
 confirmed effects in the exposed animals only. Occasional signs of lung irritation were observed at lower
concentrations. The data for rabbits, dogs, and monkeys are limited by the use of three animals or less.
In a protocol using repeated exposures (6 weeks, 5 days/week, 8 hours/day), only guinea pigs showed
histopathological changes, which included some congestion and emphysema at 1,353 mg/m3; this was
interpreted as a possible mild irritant effect. In another study, some guinea pigs exposed continuously for
90 days to 892 mg/m3 of vaporized mineral spirits (20% aromatics) also had pneumonitis, but the authors
did not associate the disorder with the exposure (Jenkins et al. 1971).  No other lung injury was evident in
this latter study either. No respiratory effects were noted in rats exposed to 5,620 mg/m3 of completely
vaporized C10-C11 isoparaffins for up to 12 weeks (6 hours/day, 5 days/week) (Phillips and Egan 1984b).
Rats exposed to 2,290 mg/m3 for 6 months (6 hours/day, 5 days/week) to white spirit (20% aromatics)
showed a bloody nasal discharge (Ostergaard et al. 1993).
Cardiovascular Effects. Men exposed in an experimental setting to up to 2,500 mg/m3 (476 ppm)
of vaporized white spirits (83% aliphatic and 17% aromatic components) for 30 minutes had no
compound-related changes in electrocardiograms, oxygen uptake, cardiac output, alveolar ventilation,
or heart rate measured at rest or during exercise (Astrand et al. 1975). A retrospective cohort study
showed no changes in blood pressure in house painters who were exposed to unspecified levels of




Studies in animals showed no histopathology in the hearts of rats, rabbits, guinea pigs, dogs, or
monkeys exposed to 1,271 mg/m3 of vaporized mineral spirits with a composition similar to Stoddard
solvent continuously for 90 days or up to 1,353 mg/m3 for 6 weeks (5 days/week, 8 hours/day) 
(Rector et al. 1966).  The data for rabbits, dogs, and monkeys are limited by the use of three animals or less.  
No cardiovascular effects were noted in rats exposed to 5,620 mg/m3 of completely vaporized C10-C11
 isoparaffins for up to 12 weeks (6 hours/day, 5 days/week) (Phillips and Egan 1984b).
Gastrointestinal Effects. Twelve volunteers exposed to 610 mg/m3 of vaporized white spirits
(57% alkanes, 25% cycloalkanes, 18% aromatics) for 6 hours reported no nausea, diarrhea, or
vomiting (Pedersen and Cohr 1984a). When Stoddard solvent was used as a machine cleaner, only
one of nine workers interviewed complained of nausea (Larsen and Schmunes 1974); exposure
duration and levels were not reported.
Transient diarrhea was noted in some guinea pigs exposed to 892 mg/m3 of vaporized mineral spirits
continuously for 90 days (Jenkins et al. 1971). No gastrointestinal effects were noted in rats exposed
to 5,620 mg/m3 of completely vaporized C10-C11 isoparaffins for up to 12 weeks (6 hours/day,
5 days/week) (Phillips and Egan 1984b).
Hematological Effects. Case reports and epidemiological studies of humans exposed to unspecified levels of 
Stoddard solvent or white spirits in the workplace revealed mixed results. From the limited data available, 
it is not possible to conclude whether Stoddard solvent adversely affects the hematological system or not. A 
study of 45 car repair workers who were exposed to a variety of solvents showed statistically significant decreased 
red blood cell counts, increased mean erythrocyte volumes, and increased platelet volumes when compared to office 
workers who had no contact with organic solvents (Beving et al. 1991). One study of 52 house painters who 
were chronically exposed to solvents found statistically significant decreases in hemoglobin concentration as 
compared to unexposed workers from other industries (Hane et al. 1977). In one series of case reports, normal
hematological values were noted in 128 persons exposed to a variety of solvents, including white
spirits (Flodin et al. 1984). Case reports exist for persons who had aplastic anemia and who also were
exposed to Stoddard solvent, but a causal relationship was not established (Prager and Peters 1970;
Scott et al. 1959).
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Normal leukocyte, hemoglobin, and hematocrit levels were found in rats, rabbits, guinea pigs, dogs,
and monkeys exposed to 1,271 mg/m3 of vaporized mineral spirits continuously for 90 days or up to
1,353 mg/m3 for 6 weeks (5 days/week, 8 hours/day) (Rector et al. 1966). The data for rabbits, dogs,
and monkeys is limited by the use of three animals or less. These results were repeated in another 13-
week exposure study that intermittently (5 days/week, 6 hours/day) exposed rats and dogs to higher
levels of completely vaporized Stoddard solvent (1,900 mg/m3) (Carpenter et al. 1975a, 1975b). No
hematological effects were noted in rats exposed to 5,620 mg/m3 of completely vaporized C10-C11
isoparaffins for up to 12 weeks (6 hours/day, 5 days/week) (Phillips and Egan l984b).
Musculoskeletal Effects. The only available human information is from two laboratory studies.
One found no changes in serum creatine kinase (an indicator of muscle cell membrane integrity) in
12 men exposed to 610 mg/m3 of three different formulations of white spirits for 6 hours (Pedersen
and Cohr 1984a). The subjects did not complain of muscle weakness. Another study of the alkane
components did show increased creatine kinase (59% and 76% above baseline for 96 and 168 hours
post-exposure, respectively) from exposure to 616 mg/m3 of vaporized white spirits (99% alkanes; i.e., lacking
aromatic components) for a slightly longer period (6 hours/day for 5 days) (Pedersen and Cohr 1984b).
No animal studies were located that showed musculoskeletal effects. Rats exposed to 5,620 mg/m3 of
completely vaporized C10-C11 isoparaffins for up to 12 weeks (6 hours/day, 5 days/week) did not show
any clinical or histopathological changes in musculoskeletal parameters (Phillips and Egan 1984b).
Rats that were exposed to white spirits at concentrations of 2,290 or 4,580 mg/m3 showed significant
increases in serum creatinine, but since no dose response was evident, the results were not definitive
(Ostergaard et al. 1993).
Hepatic Effects. The few available studies regarding hepatic effects indicate that acute, low-level
exposures to Stoddard solvent have very minor, if any, effects on liver function. A laboratory study of
12 men exposed-to 610 mg/m3 of vaporized white spirits (with a composition similar to Stoddard
solvent) for 6 hours revealed no changes in serum liver products (glucose, triglycerides, cholesterol, or
urate) (Pedersen and Cohr 1984a) as compared to pre-exposure control levels. A case report describes
painters who were exposed to unspecified levels of white spirits and other chemicals for chronic
periods; elevated levels of serum alanine aminotransferase, but normal liver biopsies (no necrosis,
steatosis, or portal tract changes), were reported (Dossing et al. 1983). A second case report describes
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a group of patients exposed to a variety of solvents, including white spirits, who had mostly normal
liver parameters, except for elevated glutamyl transferase levels (Flodin et al. 1984). In a prospective
cohort study, a third group of painters showed normal serum transaminase levels when compared to
unexposed industrial workers (Hane et al. 1977).
Guinea pigs exposed to 1,271 mg/m3 of vaporized white spirits continuously for 90 days had no
consistent pathological liver effects (Rector et al. 1966). Guinea pigs exposed to 892 mg/m3 of
vaporized white spirits continuously for 90 days had minimal fatty changes in the liver (Jenkins et al.
1971), but the authors did not attribute this to the exposure. No consistent liver histopathology was
seen in rats or guinea pigs exposed to 1,353 mg/m3 intermittently (8 hours/day, 5 days/week) for
6 weeks (Rector et al. 1966) or in rats exposed to 5,620 mg/m3 of C10-C11 isoparaffins for up to
12 weeks (6 hours/day, 5 days/week) (Phillips and Egan 1984b). Serum indicators of liver function
were normal in rats and dogs exposed intermittently (13 weeks, S/days week, 6 hours/day) to
1,900 mg/m3 of completely vaporized Stoddard solvent (Carpenter et al. 1975a, 1975b).
Renal Effects. While the available human studies do not indicate that Stoddard solvent is harmful to
human kidneys, the studies lack sufficient exposure data to draw any firm conclusions. In laboratory
studies, humans exposed to 610 mg/m3 for 6 hours showed normal serum sodium and potassium,
normal urine albumin, and normal β-2-microglobulin levels as compared to pre-exposure levels
(Pedersen and Cohr 1984a). β-2-Microglobulin is a protein found in humans, and it should not be
confused with α2u -globulin which is primarily found in male rats. One case-control study of persons
with glomerulonephritis revealed no differences in occupational and/or household use exposures to
organic solvents between cases and controls (van der Eaan 1980). However, another case-control
study showed a significantly greater exposure of patients with glomerulonephritis to petroleum
products, in particular, to greasing/degreasing agents (Yaqoob et al. 1992), but the sample population
was small and specific agents were not identified. In a case report, patients who were exposed to
white spirits and other solvents for 3-22 years exhibited serum and urinary parameters for kidney
function within the normal range for the general population (Flodin et al. 1984). A 29-year-old male
exposed by direct dermal contact and inhalation of Stoddard solvent vapors exhibited
glomerulonephritis (Daniel1 et al. 1988). See Section 2.2.3.2 for additional details of this case. A
cause-effect relationship could not be established in one case where renal failure occurred in an
individual exposed to mineral spirits (Narvarte et al. 1989). Rats exposed to white spirit (2,290 or
4,580 mg/m3) for 6 hours/day over a 6-month period showed increases in blood urea nitrogen (BUN)
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2 weeks after treatment ended. However, possible renal effects indicated by these results are equivocal
as there was no dose response noted (Ostergaard et al. 1993).
Rabbits, guinea pigs, dogs, and monkeys that were exposed to vaporized mineral spirits at
1,271 mg/m3 for 90 days did not have kidney pathology (Rector et al. 1966). The data for rabbits,
dogs, and monkeys are limited by the use of three animals or less. No kidney histopathology was
observed in guinea pigs exposed to 1,353 mg/m3 (8 hours/day, 5 days/week) intermittently for 6 weeks (Rector et al.
1966). Dogs that were exposed to 1,900 mg/m3 of completely vaporized Stoddard
solvent for 6 hours/day, 5 days/week for 13 weeks had no adverse kidney effects (Carpenter et al.
1975a, 1975b). Guinea pigs exposed to 892 mg/m3 of vaporized white spirits for 90 days showed
slight increases in blood urea nitrogen levels, but statistical analyses were not performed and no
histopathological changes in the kidneys were noted that could be attributed to exposure (Jenkins et al.
1971).
In contrast, studies with Stoddard solvent and closely related mixtures demonstrated renal damage in
male rats. When compared to controls, significantly more proximal renal tubule regeneration and
dilated, debris-filled loops of Henle were observed in male rats exposed for 13 weeks to 1,900 mg/m3
of completely vaporized Stoddard solvent (boiling range, 152.7-194.4°C; 47.7% paraffins, 26%
monocycloparaffins, 11.6% dicycloparaffins, and 14.1% alkylbenzenes) (Carpenter et al. 1975a,
1975b). Similar results were reported in a study in male rats that were exposed to 570 or 4,580 mg/m3
of Varsol 1 vapor (6 hours/day, 5 days/week) for 8 weeks (EPA 1984d), although these effects were
not observed in females even at high dose. More detailed studies were conducted with hydrocarbons
corresponding to the C10-C11 or C12 alkane fractions of Stoddard solvent.
Fischer-344 rats of both sexes were exposed to 1,840 mg/m3 or 5,450 mg/m3 C10-C11 isoparaffinic
solvent (boiling point range, 156-176°C) for up to 8 weeks (Phillips and Egan 1984a). No differences
from unexposed controls were observed in the female rats, except that after 4 weeks of exposure to
5,450 mg/m3, they excreted significantly more urinary protein, but this effect was not seen at other
times or doses. In contrast, exposed males consistently showed a variety of effects suggestive of mild
proximal tubule damage. At both doses, urine concentrating ability after overnight water deprivation
decreased significantly compared to controls after 4 or 8 weeks of exposure. After 4 weeks of
recovery from the 8-week exposure to 5,480 mg/m3, the urine concentrating ability remained
significantly different from controls. Four or 8 weeks of exposure also caused a significant increase
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in total urine protein and glucose excreted in the urine at either dose, but this effect disappeared after
4 weeks of recovery. In the serum, coordinate changes were seen with increased blood urea nitrogen
(BUN) and creatinine and reduced glucose levels. Creatinine clearance was significantly decreased
after 8 weeks of exposure to 5,450 mg/m3, but recovered to control levels after 4 weeks with no
exposure. At both doses after 4 or 8 weeks of exposure, there was a remarkable increase in epithelial
cells sloughed into the tubule and recovered in the urine; this ceased after 4 weeks of recovery time.
In histological sections, epithelial regeneration and tubular dilation were scored, and their incidence
and degree increased with time at both exposure levels; the 4-week absence from exposure did not
result in complete recovery. However, the authors emphasized that this structural damage was only
observed in 5-10% of tubules Increased numbers of protein droplets were observed in the cytoplasm
of renal tubular epithelial cells from 1 week after exposure began onward, but these droplets were not
assayed to determine their α2u -globulin content (Phillips and Egan 1984a).
A parallel experiment using both electron and light microscopy showed an increase in the number of
hyaline droplets, which are characteristic of resorbed protein; this increase was proportional to
exposure duration and concentration and could be observed after 5 days of exposure (Phillips and
Cockrell 1984). The S2 portion of the proximal convoluted tubule was most affected. The severity of
the droplet accumulation and other pathological changes decreased after the 4-week recovery period.
Positive acid phosphatase staining was consistent with the droplets being lysosomes, and electron
microscopy demonstrated that the droplets were membrane enclosed, as expected of lysosomes
(Phillips and Cockrell 1984). Parallel experiments in Sprague-Dawley rats with dearomatized white
spirit (aromatics <0.5%, 58% paraffins, 42% cycloalkanes, mainly C11-C12; boiling range, 155-193°C) 
and C10-C11 isoparaffins (boiling range, 156-176°C) resulted in similar, but less pronounced, 
renal histopathology (Phillips and Egan 1984b). In male but not female Fischer-344 rats, similar
experiments with Stoddard solvent of unspecified composition showed comparable pathological
changes and significant differences from control in urinary glucose and protein excretion and urine
concentration at 570 mg/m3 and 4,580 mg/m3, respectively, after as few as 4 weeks of exposure
(Phillips 1983). All-the pathological and functional changes observed in this experimental series are
consistent with an α2u -globulin mechanism for renal toxicity to the proximal tubule (Phillips 1983;
Phillips and Cockrell 1984; Phillips and Egan 1984a, 1984b).
Similarly, male Sprague-Dawley rats exposed to completely vaporized white spirits (99% C10-C12
alkanes) at 6,500 mg/m3 for 5 weeks (8 hours/day, 5 days/week) or more showed increased excretion
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of albumin; female rats and castrated males were unaffected (Viau et al. 1986). The authors attributed
this albuminuria to glomerular leakage since tubular resorption of a smaller filtered blood protein,
β2-microglobulin, was unaffected. After 5 weeks of exposure to 6,500 mg/m3, there was a significant
decrease in the ability to concentrate urine after 24 hours of water deprivation in exposed male rats,
but not in female rats or castrated males. Histopathology in male rats exposed to 6,500 mg/m3
revealed many hyaline droplets in S2 proximal tubule cells (seen after 5.5, 46, or 68 weeks of
exposure), tubular dilation with granular casts (seen only in rats after 5.5 weeks of exposure), and
regenerative epithelia in both the proximal and distal tubules. Both intact and castrated males exposed
to 6,500 mg/m3 for 5.5 weeks had significant increases (10-fold) in kidney levels of α2u -globulin compared
to their respective controls; the baseline level in castrates was an order of magnitude lower
initially. No differences were observed in levels of this protein in the liver, the site of synthesis. The
exposed intact males also had significantly increased plasma concentrations of α2u -globulin (Viau et al. 1986).
Monitoring of urinary enzyme activities suggested renal damage at sites other than the proximal
tubule. After 2 weeks of exposure to either 6500 or 580 mg/m3, there was a significant increase in
urinary lactate dehydrogenase, but not in  β-N-acetyl-D-glucosaminidase activity, in male rats exposed
to 6,500 or 580 mg/m3; lactate dehydrogenase activity was unchanged in castrated males and females
exposed similarly (Viau et al. 1986). Since β-N-acetyl-D-glucosaminidase is a proximal tubule
lysosomal enzyme while lactate dehydrogenase is a cytosolic enzyme characteristic of lower nephron
regions including the loop of Henle, distal tubule, and collecting duct, the authors’ interpretation of
their results was that the damage is in the distal tubule rather than the proximal tubule (Viau et al.
1986; WHO 1991). However, this conclusion should be regarded with caution since activities rather
than enzyme molecules were measured and other substances in urine can sometimes effect these
enzyme activities (WHO 1991).
A number of the observed renal effects of Stoddard solvent are consistent with a mechanism which
appears to be unique to male rats. Male rodents scent mark their territories with pheromones secreted
in the urine. These pheromones are transported to the urine by low molecular weight serum binding
proteins which are members of the lipocalin family (Bocskei et al. 1992). In male rats, the carrier
protein is α2u -globulin, which is synthesized in large quantities in the liver (EPA 1991a). X-ray
crystallography has demonstrated that α2u -globulin is a tetramer which has a doughnut hole in the
center for transport of the ligand (Bocskei et al. 1992). Although the preferred pheromone ligand for
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the analogous dimeric mouse protein, mouse urinary protein, has been identified through x-ray
crystallography of the bound complex, the particular pheromone with the best fit to the α2u -globulin
tetramer has not yet been identified (Bocskei et al. 1992). After glomerular filtration with their ligand,
these carrier proteins are resorbed in massive amounts in the P2 section of the proximal renal tubule
and then catabolized in lysosomes (EPA 1991a; Kimura et al. 1991a).
Unfortunately, the α2u -globulin tetramer seems to be proficient at transporting other hydrophobic
molecules besides pheromones through the blood and into the urine. Other substances which
apparently also bind to this carrier protein include a number of hydrophobic xenobiotics such as
petroleum-derived hydrocarbons or their constituents or metabolites, including decalin and the gasoline constituent
trimethylpentane (EPA 1991a). The xenobiotic-α2u -globulin bulin complex is then reabsorbed in the proximal tubule
and accumulates in lysosomes where it resists degradation. Accumulation of this complex is thought to trigger
pathological responses within the kidney. This α2u -globulin in nephropathy syndrome is characterized by the following
lesions (Alden 1986; EPA 1991a; Lehman-McKeeman 1993; Short et al. 1987): excessive accumulation of hyaline
droplets in the P2 segment of the proximal tubule region of the kidney; association of the hyaline droplets with the
protein α2u -globulin; singlecell necrosis in the P2 segment epithelium and exfoliation of these degenerated cells;
sustained regenerative tubule cell proliferation, often with tubular dilation and tubular epithelial necrosis; accumulation
of granular casts formed from the cellular debris and subsequent tubule dilation at the junction of the P3 segment and
the thin loop of Henle; linear mineralization of the renal papillar tubules with hyperplasia of the renal pelvic
urothelium.
The hepatic synthesis of α2u -globulin is under androgenic control, and the protein is found at
concentrations 100-300 times higher in male rat urine than in female rat urine (Shapiro and
Sachchidananda 1982; Van Doren et al. 1983). Neither female rats nor castrated male rats show the
characteristic renal pathology associated with α2u -globulin nephropathy. Aging male rats show chronic progressive
nephropathy symptoms that are similar to α2u -globulin nephropathy, so it is important to run concurrent controls when
assessing renal toxicity. α2u -globulin is not present in other rodents, but mice have a similar pheromone carrier, mouse
urinary protein, which does not cause the same effects.  Although other members of the lipocalin protein family do
occur in non-rodent species, including humans, they are not produced in such massive quantities, and these species do
not exhibit renal toxicity in response to the same set of substances that produce this characteristic toxicity in male rats




similar xenobiotics or metabolites, as well as to determine whether any binding that occurred inhibited
catabolism.
Ocular Effects. No studies were located regarding systemic ocular effects in humans or in animals
after inhalation exposure to Stoddard solvent. Ocular effects that have been observed in humans and
in animals after inhalation exposure were probably due to direct contact of the vapor with the eyes
rather than to a systemic effect due to inhalation exposure. For details of these studies, see
Section 2.2.3.
Body Weight Effects. No studies were located regarding body weight effects in humans after
inhalation exposure to Stoddard solvent.  Rats, rabbits, guinea pigs, dogs, and monkeys exposed to 1,271 mg/m3 
of vaporized mineral spirits for 90 days had normal body weight gain (Rector et al. 1966). However, the data for 
rabbits, dogs, and monkeys are limited by the use of three animals or less. Normal body weight gain was also noted 
in rats and guinea pigs following intermittent exposure 8 hours/day, 5 days/week for 6 weeks to up to 1,353 mg/m3 
mineral spiritscompletely (Rector et al. 1966). No adverse effects on body weight were seen in rats or dogs exposed to 
1,900 mg/m3 vaporized Stoddard solvent 6 hours/day, 5 days/week for 13 weeks (Carpenter et al. 1975a, 1975b). 
Decreased body at weight was noted in rats exposed to white spirit (20% aromatic) for 6 months (6 hours/day, 
5 days/week) levels of4,580 mg/m3, but the percent change was not quantified (Ostergaard et al. 1993).
2.2.1.3 Immunological and Lymphoreticular Effects
In a laboratory study, humans exposed to 616 mg/m3 of vaporized white spirits (Shellsol,
approximately 99% alkanes) for 5 days, 6 hours/day, showed no changes in serum immunoglobulins
(IgG, IgA, IgM) (Pedersen and Cohr 1984b). However, this is not a complete test of immune
function. No further studies were located regarding lymphoreticular effects in humans after inhalation
exposure to Stoddard solvent.





The most sensitive indicator of toxic effects of Stoddard solvent is effects on the nervous system.
Sensitive neurological tests have revealed neurological dysfunction in humans. In a laboratory
experiment, eight sedentary men were exposed to 4,000 mg/m3 of completely vaporized white spirits
for 50 minutes (Gamberale et al. 1975). Changes were found in simple reaction time but not in
perceptual speed, short-term memory, numerical ability, or manual dexterity when compared with preand post-
exposure self controls. Another human study also showed minor neurological effects
(dizziness in two of six men tested) from a 15-minute exposure to 2,700 mg/m3 Stoddard solvent
(Carpenter et al. 1975a, 1975b). However, controls were not used for comparison in this study.
Additional data from human studies indicate levels at which neurological effects did not occur. Men
exposed for 30 minutes to up to 2,400 mg/m3 of completely vaporized Stoddard solvent at 0, 600,
1,800, and 2,400 mg/m3 had no dose-related changes in hand-eye coordination, reaction time/decision
making or video game visual motor skill/band-eye coordination challenges. When results were
compared to control values from unexposed men, there was a statistically significant difference
observed in both the eye-hand coordination test and the video game visumotor test at 600 mg/m3.
Since the results at higher exposure levels were not different from controls, 2,400 mg/m3 was
considered to be the tentative level at which no effect was observed (Hastings et al. 1984). Similarly,
perceptual speed, numerical ability, manual dexterity, reaction time, and short-term memory were not
altered by exposure to white spirits for 30 minutes at 625 mg/m3, followed by 30 minutes at
1,250 mg/m3, followed by 30 minutes at 1,875 mg/m3, followed by 30 minutes at 2,500 mg/m3.
Testing began after only 10 minutes of the 2,500 mg/m3 exposure, and the time-weighted average
exposure when testing ended was 1,563 mg/m3 (Gamberale et al. 1975). Twelve human volunteers
exposed to 610 mg/m3 of Varnoline (57% alkanes, 25% cycloalkanes, 1% alkenes, and 17.8%
alkylbenzenes) or two other white spirit formulations (99% paraffins or 52% paraffins and 48%
cycloalkanes) for 6 hours had no complaints of headache, dizziness, visual disturbances, tremor,
muscle weakness, incoordination, sleep disturbances, or skin paraesthesia within 48 hours.of the
initiation of the exposure (Pedersen and Cohr 1984a).
Neurological effects have been described in several case reports (Bruhn et al. 1981; Daniel1 et al.
11988; Flodin et al. 1984), epidemiological studies (Hane et al. 1977), and cohort studies (Arlien-
Soborg et al. 1979; Gregersen et al. 1984; Mergler et al. 1988; Mikkelsen et al. 1988; Olson 1982) in
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which workers were chronically exposed to Stoddard solvent, white spirit, or other solvents via the
inhalation or dermal routes. In these retrospective studies, the exposure concentrations were not
measured. In most cases, the exposure levels were not known and the estimated exposure did not
correlate well with the degree of impairment. Additionally, the workers were exposed to a variety of
solvents in addition to Stoddard solvent. Therefore, cause-effect relationships cannot be established.
Exposed persons have had a variety of neurological findings including headaches (in 29/50; Arlien-
Soborg et al. 1979), color blindness (66.6% of printshop workers; Mergler et al. 1988), dementia
(Mikkelsen et al. 1988), cerebral atrophy (Mikkelsen et al. 1988), memory deficits (in 45/50; Arlien-
Soborg et al. 1979; in 38/65; Gregersen et al. 1984; Hane et al. 1977), discoordination (Mikkelsen et
al. 1988), and fatigue (in 38/50; Arlien-Soborg et al. 1979; in 28/65; Gregersen et al. 1984; Hane et al.
1977). The reversibility of headaches and fatigue was not addressed in studies by Arlien-Soborg et al.
(1979), Gregersen et al. (1984), and Hane (1977). In another study however, the headaches and
fatigue did not occur once the workers were off the job for a few days (Daniell et al. 1988). In
contrast, the cerebral atrophy and memory deficits persisted several years after the workers were no
longer exposed (Bruhn et al. 1981; Gregersen 1988). The cerebral atrophy was measured by a
computerized tomography scan, and the memory deficits were revealed by a psychological
examination. Neurological examinations were also performed on these subjects. Significant decreases
on test performances of visual-biological ability and psychomotor coordination were noted among a
group of 52 housepainters in Sweden, when compared to a group of 52 non-solvent-exposed referents
(Hane et al. 1977). Information regarding dermal-exposure toxicity is also discussed for some studies
(Daniel1 et al. 1988; Mergler et al. 1988) because both inhalation and dermal exposures may have
occurred in these cases (see Section 2.2.3.4.).
When exposed for 8 hours, rats showed incoordination at 8,200 mg/m3 that was not observed at
4,600 mg/m3 and dogs had tremors and convulsions at 8,000 mg/m3; cats, exposed for 2.5-7.5 hours,
exhibited slowed light reaction, convulsions, and tremors at 10,000 mg/m3 before their death
(Carpenter et al. 1975a, 1975b). The reversibility of the effects short of death were not studied. The
data are limited for dogs and cats because only one female dog and four male cats were-tested. Rats
exposed to white spirit (20% aromatics) (6 hours/day, 5 days/week, for 6 months) showed no changes
in histopathology of the brain or in brain weight, motor or neurobehavioral activity, although a
transient narcotic effect was noted. However, neurochemical analyses showed significant increases in
noradrenaline, dopamine, and 5-hydroxytryptamine levels in certain regions of the brain at 2,290 and
4,580 mg/m3. No effects on motor activity were noted on weekends between weekday exposures. The
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study was limited in that neurobehavioral testing occurred 2 months after exposure and only two doses
were tested (Ostergaard et al. 1993). Stoddard solvent does not contain the short-chained alkanes
hydrocarbons that are known to cause anesthesia (Haydon et al. 1977). There are no available
intermediate- or chronic-duration studies of neurophysiological or behavioral effects in animals. All
reliable NOAELs and LOAELs for neurological effects in humans and animals are recorded in Table
2-l and plotted in Figure 2-1.
2.2.1.5 Reproductive Effects
Seven men who were exposed for 6 hours/day for 5 days to 616 mg/m3 of vaporized white spirits
(with a composition of 99% alkanes, as compared to 30-50% alkanes in Stoddard solvent) had a
decrease (p<0.05) in serum follicle-stimulating hormone levels at 24 and 96 hours after the initiation
of exposure as compared to pre-exposure levels (Pedersen and Cohr 1984b). This change did not
correspond to blood or adipose levels of white spirits. No tests of reproductive function were
performed. In another study, 11 men in a printing factory were occupationally exposed to a wide
variety of solvents, including 294 mg/m3 of white spirits for 1-17 years. Sperm counts, motility, and
morphology were monitored for 2 months, and all values were normal (Tuohimaa and Wichmann
1981).
No studies were located regarding reproductive effects in animals after inhalation exposure to Stoddard solvent.
2.2.1.6 Developmental Effects
No studies were located regarding developmental effects in humans after inhalation exposure to
Stoddard solvent.
Offspring of rats exposed to up to 2,356 mg/m3 of Stoddard solvent vapor for 6 hours/day during
gestation days 6-15 had no compound-related skeletal or visceral abnormalities. Average fetal weights
were not changed, nor was the mean litter size (API 1977). There was no compound-related maternal
toxicity. Some of the litters included animals with skeletal variations, but the incidences of these
variations were not dose related and were not considered to be malformations by the study authors.




No studies were located regarding genotoxic effects in humans after inhalation exposure to Stoddard
solvent.
Exposure to vaporized white spirits at 50,000 mg/m3 for five periods lasting 5 minutes each failed to
significantly increase bone marrow micronuclei in four male mice (Gochet et al. 1984). Each 5-minute
period of exposure was separated from the next by an additional 5 minutes.
Other genotoxicity studies are discussed in Section 2.4.
2.2.1.8 Cancer
Human data are available from a case-control study of 32-100 individuals who had cancer and who
were questioned on their exposure to petroleum products (Siemiatycki et al. 1987). Statistically
significant positive odds ratios were found for mineral spirits and prostate cancer. Nonsignificant but
positive odds ratios were also reported for Hodgkin’s lymphoma and squamous cell carcinoma of the
lung. However, squamous cell carcinoma of the lung was of “borderline” significance since the OR
was determined to be 1.2 (90% CI: 1.0-1.5). The study only tested one hypothesis, based on the
association between exposure and cancer. The study authors could not provide a mechanistic
explanation for the association between solvent exposure and prostate cancer or lymphomas. The
study did not have the statistical power to establish a link between exposure to mineral spirits and lung
cancer because the confidence intervals (90%) around the odds ratio estimates were too wide to
suggest a correlation. A case-referent study using cases of Hodgkin’s disease and non-Hodgkin’s
lymphoma among Swedish workers exposed to white spirits implied a slight increase in crude odds
ratios, but the study was limited by an insufficient number of cases (Persson et al. 1993).
No studies were located regarding cancer in animals after inhalation exposure to Stoddard solvent,
2.2.2 Oral Exposure
No studies were located regarding human or animal health effects following oral exposure to Stoddard
solvent for any end point or duration category. In general, ingestion of most petroleum distillates at
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doses less than 1,000 mg/kg causes little toxicity (Ellenhorn and Barceloux 1988). For further
information, see the ATSDR toxicological profiles on gasoline, jet fuels, or fuel oils (ATSDR 1993).
It is possible that if Stoddard solvent were swallowed, some would be taken into the lungs by
aspiration, and this would be expected to cause pneumonitis (Ellenhorn and Barceloux 1988).
No studies were located regarding the following end points after oral exposure to Stoddard solvent:
2.2.2.1 Death
2.2.2.2 Systemic Effects





Genotoxicity studies are discussed in Section 2.4.
2.2.2.8 Cancer
No studies were located regarding carcinogenic effects in humans or animals following inhalation
exposure to Stoddard solvent.
2.2.3 Dermal Exposure
Because of the lack of quantifiable exposure data for other effects, only studies showing ocular effects
after dermal exposure are suitable for presentation in a table on levels of significant exposure. See
Table 2-2. Ocular effects noted in this section occurred after inhalation exposure to Stoddard solvent.
However, these ocular effects are probably due to direct contact with the eyes rather than as a systemic effect





No studies were located regarding death in humans or animals after dermal exposure to Stoddard
solvent.
2.2.3.2 Systemic Effects
No studies were located regarding respiratory, cardiovascular, gastrointestinal, hematological,
musculoskeletal, or hepatic effects in humans or animals after dermal exposure to Stoddard solvent.
Renal Effects. The only information on the possible effects of Stoddard solvent on the kidneys of
humans after dermal exposure comes from an occupational case study. A 29-year-old man handled
brushes soaked in Stoddard solvent while not wearing gloves for 1 year and developed glomerulonephritis
(Daniell et al. 1988). On a typical day, he spent about 6 hours using the solvent. The patient’s glomerulonephritis
was associated with antibodies to the glomerular basement membrane.  Exposure concentrations were not reported.
Both dermal and inhalation exposure are likely in this case.
No studies were located regarding renal effects in animals after dermal exposure to Stoddard solvent.
Dermal Effects. Five men who wore coveralls that were damp from dry cleaning with Stoddard
solvent developed sores on the penis and buttocks (Nethercott et al. 1980). None had an allergic
reaction in a patch test. Standard texts and review articles on industrial hygiene list Stoddard solvent
or Varsol as a possible eye, skin, nose, and throat irritant (Birmingham 1988; McDermott 1975;
NIOSH 1990; Sax and Lewis 1989).
Dermal exposure to white spirits (three times daily for 3 days) resulted in skin irritation in guinea pigs as evidenced by
an increase in mean epidermal thickness, visible redness, palpable induration, and evident swelling (Anderson et al.
1986).
Ocular Effects. Humans exposed to 600 mg/m3 or up to 1,800 mg/m3 of completely vaporized
Stoddard solvent for 30 minutes in separate experiments in a controlled laboratory setting showed no
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eye irritation as indicated by eye blinks but individuals exposed to 2,400 mg/m3 exhibited eye irritation as measured by
eye blink rate (Hastings et al. 1984). However, subjectively reported slight eye irritation occurred in individuals
exposed to 2,700 mg/m3 of completely vaporized Stoddard solvent for 15 minutes (Carpenter et al. 1975a, 1975b).
Eye irritation was also seen in rats during acute inhalation exposure to 4,600 mg/m3 of completely
vaporized Stoddard solvent and in dogs exposed to 8,000 mg/m3 (Carpenter et al. 1975a, 1975b).
Lacrimation was noted in rats exposed by inhalation for 6 months (5 days/week, 6 hours/day) to
2,290 mg/m3 white spirit (20% aromatics) (Ostergaard et al. 1993). Although these effects were
reported after inhalation exposure to Stoddard solvent, they are probably due to direct contact of the
vapor with the eyes rather than to a systemic effect.
2.2.3.3 Immunological and Lymphoreticular Effects
No studies were located regarding immunological or lymphoreticular effects in humans or animals
after dermal exposure to Stoddard solvent.
2.2.3.4 Neurological Effects
A 29-year-old man who used Stoddard solvent as a cleaning agent while not wearing gloves, for
approximately 6 hours per day for 1 year, occasionally reported feeling “high” and experienced
bifrontal headaches that began during work and subsided in the evenings and over weekends (Daniel1
et al. 1988). Exposure concentrations were not reported. Both dermal and inhalation exposure are
likely in this case.
In another occupational study, the incidence of acquired color vision loss (dyschromatopsia) was
investigated in 30 printshop employees exposed by the inhalation and dermal routes (Mergler et al.
1988). The employees were divided into three groups based on product exposure: (1) graphics
department workers with occasional exposure to heated wax, (2) photo- and polycopy operators with
exposure to solvents containing alcohols, perchloroethylene, and Stoddard solvent, and (3) bookbinders and printers
with exposure to solvents containing methylene chloride, xylene, toluene, and Stoddard solvent. When compared to the
controls, the printshop employees as a whole had a significantly higher mean color confusion index. Furthermore,
groups 2 and 3 of the solvent-exposed employees
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had higher incidences of color confusion than group 1. The employees in groups 2 and 3 also
exhibited complex color vision loss (i.e., both blue-yellow and red-green loss), whereas the controls
and exposure group 1 only had blue-yellow loss. The color confusion index was related to both age
and job type, but complex color loss was only related to job type. This study suggests that solvents,
possibly including Stoddard solvent, may cause neurological damage in the form of acquired color
vision loss. However, since the workers were exposed to multiple solvents simultaneously, it is
impossible to determine which solvent or combination of solvents may have produced the
dyschromatopsia. In addition, neither exposure doses nor durations were discussed.
Only one study was located regarding neurological effects fn animals after dermal exposure to
Stoddard solvent. Rats had a daily 3-hour exposure to white spirits for 6 weeks on a 12-cm2 area of
the tail (Verkkala et al. 1984). The absorbed dose was calculated by the authors to be 210 mg, but
they did not describe how the calculation was performed. Exposure had little effect on motor
conduction velocity or motor amplitudes in response to stimulation. Histological analysis revealed
axonal prenodal swellings. No other functional or behavioral tests were performed.
No studies were located regarding the following health effects in humans or animals after dermal




Genotoxicity studies are discussed in Section 2.4.
2.2.3.8 Cancer
A case-referent study using cases of Hodgkin’s disease and non-Hodgkin’s lymphoma among Swedish workers
exposed to white spirit implied a slight increase in crude odds ratios, but the study was limited by an insufficient
number of cases (Persson et al. 1993).
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Squamous cell carcinomas were found in 6 out of 50 exposed mice from a lifetime skin-painting study
using a rust-preventive compound consisting of 90% Stoddard solvent, 7% calcium petroleum
sulfonate, and 3% ethylene glycol monobutyl ether (EPA 1984~). No tumors were found in mineral
oil controls. Since the test involved three constituents, it is not possible to determine which one or
combination was responsible for the tumors. In fact, none of the three substances has previously been
identified as a carcinogen. The design of this study makes the results too ambiguous to determine
whether Stoddard solvent is carcinogenic, but it does suggest a potential area of concern. The
possibility that Stoddard solvent could initiate or promote squamous cell carcinomas should not be
completely discounted until a similar experiment using Stoddard solvent alone is conducted.
2.3 TOXICOKINETICS
The toxicokinetic properties of Stoddard solvent are not well defined by the available data. Some
toxicokinetic data that are specific to the three classes of Stoddard solvent components (i.e., alkanes,
cycloalkanes, and aromatics) are available.
Studies in humans and animals have shown that Stoddard solvent and white spirits are readily
absorbed through the lungs. In general, it can be expected that Stoddard solvent components such as
the aromatics, which have higher blood/gas solubility ratios, would be more completely absorbed
through the lungs that those with lower ratios (Klaassen 1991). Aliphatic components of white spirit
have been shown to have only limited blood solubility, while aromatic components were relatively
soluble (Astrand et al. 1975). No studies were located that reported the absorption of Stoddard solvent
after oral exposure in either humans or animals. However, from studies of other petroleum distillates,
it is expected that certain components of Stoddard solvent (smaller alkanes or aromatics) might be
more readily absorbed than other components such as longer (C10-C16). alkane chains. Neither human
nor animal studies evaluating the absorption of Stoddard solvent after dermal exposure were located,
but dermal absorption in rats is known to have occurred after application of white spirits. Aromatic
components would be expected to have greater dermal absorption than aliphatic components.
White spirits has been found to accumulate in the blood and subcutaneous fat of humans following
inhalation exposure. The uptake of aliphatic components in blood was lower than the uptake of
aromatic components (Astrand et al. 1975). It is believed that white spirits can enter the brain of
humans since neurological effects have been reported; however, no human data are available to verify
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this. White spirits has been shown to accumulate in the rat brain after inhalation exposure (Lam et al.
1992). There is no information available on the distribution of Stoddard solvent following oral or
dermal exposure.
Elevated levels of dimethylbenzoic acid, a metabolite of trimethylbenzene (a constituent of Stoddard
solvent) were identified in the urine of humans exposed to a mist of white spirits (Pfaffli et al. 1985).
Correlations were found between exposure concentrations of 1,2,4-trimethylbenzene and urinary
concentrations of its metabolite, 3,4-dimethylhippuric acid (Fukaya et al. 1994). No other studies were
located regarding metabolism following exposure to Stoddard solvent.
Although no studies were found that reported the excretion of Stoddard solvent after inhalation or oral
exposure in humans and animals, or after dermal exposure in humans, it is expected that volatile
components or metabolites of Stoddard solvent that have low blood solubility would be most easily
excreted in exhaled breath (Klaassen and Rozman 1991). Aromatic components, which have high
blood/gas solubility ratios, would be expected to be excreted primarily in urine. After dermal
exposure to white spirits, rats were found to excrete dimethylbenzoic acid isomers in the urine
(Verkkala et al. 1984).
The mechanism of action on the target organ (i.e., the brain) of humans is not known.
2.3.1 Absorption
2.3.1.1 Inhalation Exposure
Following acute inhalation exposure of humans to white spirits (600 mg/m3 in a laboratory setting),
white spirits were found in the blood and subcutaneous fat (Pedersen et al. 1984, 1987). The white
spirits consisted of 99% alkanes (C8-C12), which is greater than the 30-50% alkanes found in Stoddard
solvent. The spectrometrical pattern produced by the evaporation of the biopsy samplesindicated that
the approximately 200 constituents of the white spirits were absorbed differently. The calculated
pulmonary uptake from an exposure to 600 mg/m3 for 3 hours was about 400 mg (133 mg/hour) in
men who weighed an average of 73±8 kg (Pedersen et al. 1987). Mean residence time was 47.5 hours
(Pedersen et al. 1987). The volume of distribution at steady state was 749 L, indicating that
concentration was occurring in a compartment such as adipose tissue. Total body clearance was
STODDARD SOLVENT 46
2. HEALTH EFFECTS
263 mL/minute (Pedersen et al. 1987). The calculated uptake for exposure to the same level for a
longer period (5 days, 6 hours/day) was 3,464±329 mg (115±211 mg/hour). Thus, the rate of inhalation absorption was
fairly constant over the different exposure intervals measured here. Mean blood concentration was 2 mgL on day 1 and
2.54 mg/L on day 5, showing accumulation of white spirits in the blood (Pedersen et al. 1984). There are no other
studies from animals or humans that can be used to verify these results.
In general, it can be expected that the more highly volatile components of Stoddard solvent would
cross from the lungs into the bloodstream more readily than other components (Klaassen 1991). The
components with higher blood/gas phase solubility ratios (such as the aromatics: substituted benzenes
and toluenes) would be expected to be absorbed more completely than those with lower ratios (such as
the cyclohexanes) (Klaassen 1991).
Men exposed to up to 2,000 mg/m3 of white spirits (83% aliphatic and 17% aromatics) for 30 minute
intervals per concentration during rest in the laboratory bad average uptakes of 50% for the aliphatic
components and 62% for the aromatics, as determined by measuring the representative components
(n-decane and 1,2,4-trimethylbenzene) in inspiratory and expiratory air (Astrand et al. 1975). The
exposure sequence of another experiment in the same study consisted of 30-minute exposure periods
interrupted by three 30-minute exercise periods. Pre-exercise concentrations of alveolar air in subjects
exposed to 1,250 mg/m3 of white spirits for 30 minutes at rest were 256 mg/m3 of aliphatic
components and 27.8 mg/m3 of aromatic components; arterial blood concentrations were 1.7 mg/kg for the
aliphatics and 0.2 mg/kg for the aromatics (Astrand et al. 1975). After exercise, alveolar air
concentrations increased to approximately 513 mg/m3 (aliphatics) and 40 mg/m3 (aromatics); arterial
blood concentrations increased to 3.5 mg/kg (aliphatics) and 0.9 mg/kg (aromatics) (Astrand et al.
1975). Thus, the aromatics appear to be more soluble in blood and more efficiently absorbed through
the lungs. Due to increased respiration that occurs during exercise, more of the solvent is taken up at
this time than during sedentary periods.
2.3.1.2 Oral Exposure
No studies were located regarding absorption of Stoddard solvent following oral exposure in humans
or animals. Other petroleum distillates with longer carbon chains, such as kerosene (C10-C16), are very
poorly absorbed from the gastrointestinal tract (Dice et al. 1982; Mann et al. 1977; Wolfsdorf and
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Kundig 1972). The smaller (C9-C11 alkane or aromatic hydrocarbons (10-20% in Stoddard solvent)
may be more readily absorbed (Litovitz and Greene 1988). The rate and extent of gastrointestinal
absorption would be expected to be dependent on the lipophilicity and size of the various components
and the amount of food in the stomach.
2.3.1.3 Dermal Exposure
No studies were located that evaluated absorption foollowing dermal exposure to Stoddard solvent in
humans or animals. However, daily applications of white spirits (absorbed dose 690.8 mg/kg) for
6 weeks on the tail of rats were associated with axonal prenodal swellings (Verkkala et al. 1984)
indicating that dermal absorption had occurred. This study also reported that several products
(dimethylbenzoic acid isomers) of trimethylbenzene metabolism were found in the urine of treated rats, providing
further evidence of dermal absorption. The aromatic hydrocarbons are expected to have
higher skin penetration than the aliphatic hydrocarbons.
2.3.2 Distribution
2.3.2.1 Inhalation Exposure
Following acute inhalation exposure of eight male individuals to white spirits (Shellsol, 99% alkanes,
at 600 mg/m3 for 3 hours or 6 hours/day for 5 days), white spirits was found to accumulate in the
blood and subcutaneous fat (Pedersen et al. 1984, 1987). For the single exposure, the estimated mean
half-life in fat was 46 hours. Following repeated exposures to white spirits, the mean concentration in
the fat was 41.l mg/kg (Friday afternoon) (Pedersen et al. 1984). On Monday morning, the
concentration in fat was 31.7 mg/kg, indicating that only 23% was removed over the period of
nonexposure. The concentration of white spirit in fat found each afternoon correlated significantly
with the total dose (Pedersen et al. 1984). A mathematical model was developed using measured
blood values to calculate concentrations in various tissues (Pedersen et al. 1987). The model was
considered to be a good predictor of tissue concentration since measured blood and fat values closely
followed the fitted values. The partition coefficient for adipose tissue:blood was calculated to be 47.
Estimated maximum steady-state concentrations were about 55 mg/kg for fat and 5 mg/kg for brain;
estimated minimum steady-state concentrations were 35 mg/kg for fat and 0.6 mg/kg for brain
(Pedersen et al. 1987). No other human or animal data are available to verify this calculation. Since
STODDARD SOLVENT 48
2. HEALTH EFFECTS
central nervous system effects are common following exposure to white spirits, it can probably enter
the brain The study described above uses mathematical calculations to estimate how much could
enter the brain, based on distribution to fat and to blood, but the study did not actually measure
distribution to this organ. A 3-week inhalation study in Wistar rats exposed for 6 hours/day,
5 days/week at levels of 2,290 and 4,580 mg/m3 found that white spirits (20% aromatics) accumulated
in the brain (3.4 and 10.2 mg/kg wet weight, respectively) (Lam et al. 1992). This study also
measured the distribution of aromatic and aliphatic components; aliphatics seemed to accumulate more than 
aromatics.  In the brain, aromatic compounds of white spirits increased proportionately with the exposure level 
(2.1 times), while metabolic elimination aromatic aliphatic compounds increased 3.6 times. This may be due to 
an increased metabolic elimination of the components (Zahlsen et al. 1992). No studies using Stoddard 
solvent or white spirits were available in which distribution to any other organs was measured.
Distributions of some possible components of Stoddard solvent have also been examined. A
toxicokinetic study on the distributions of C9-C10, alkanes, aromatics, and cycloalkanes in blood, brain, liver, kidney,
and perirenal fat was performed in rats after inhalation exposure 12 hours/day for up to 3 days at 100 ppm (Zahlsen et
al. 1992). The compounds tested included n-nonane and n-decane (alkanes), trimethylbenzene and t-butylbenzene
(aromatics), and trimethylcyclohexane and t-butylcyclohexane (cycloalkanes). It was reported that aromatics generally
showed higher blood concentrations than alkanes and cycloalkanes. C9 cycloalkanes showed higher brain
concentrations than the corresponding aromatics and alkanes, while brain concentrations of C10 alkanes were slightly
greater than C10 cycloalkane concentrations, which in turn were greater than C10 aromatic concentrations (Zahlsen et al.
1992). Fat contained the highest concentrations of each of the hydrocarbons examined; concentrations of aromatics and
cycloalkanes in fat were higher than concentrations of alkanes. The concentrations of aromatics in fat decreased on
each successive day of exposure, which could be an indication of a higher rate of metabolic elimination (Zahlsen et al.
1992). C9 alkanes were found in particularly low concentrations in the liver compared to levels found in the brain and
kidney.  Although C9 alkane levels were similar in the brain and kidney, C10 alkane levels were found to be slightly
higher in the brain. Concentrations of trimethylcyclohexane and trimethylbenzene were higher in kidney tissue than
were concentrations of the alkanes (Zahlsen et al. 1992).
Rats exposed by inhalation to 1,000 ppm of trimethylbenzene, n-nonane, or trimethylcyclohexane
(12 hours/day for up to 14 days) reported that after the first day of exposure, trimethylbenzene showed
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the greatest blood concentration (537 µmol/L) followed by n-nonane (174 µmol/L) and
trimethylcyclohexane (130 µmol/L) (Zahlsen et al. 1990). However, n-nonane showed the highest
brain concentration (1,416 µmol/kg), while concentrations of trimethylcyclohexane (1,109 µmol/kg)
and trimethylbenzene (998 µmol/kg) were somewhat similar. This finding was in contrast to the later
Zahlsen et al. (1992) study in which C9 cycloalkanes showed higher brain concentrations than alkanes.
In perirenal fat, the highest concentrations were of trimethylbenzene (49,190 µmol/kg on day l),
followed by n-nonane (15,980 µmol/kg on day 3) and trimethylcyclohexane (6,860 to 9,550 µmol/kg
throughout exposure) (Zahlsen et al. 1990). The concentrations in perirenal fat in the later Zahlsen et
al. (1992) study again were different from these earlier results; concentrations of aromatics were
greater than those of cycloalkanes, which were greater than those of alkanes. It is possible that the
results of these studies differ due to saturation of metabolic pathways, since the concentrations used in
the two studies differed by 10-fold. In the Zahlsen et al. (1990) study, although there was some
overall decrease in the concentrations of all three compounds in blood, brain, and fat over the total
period of exposure, the decreases were most prominent following exposure to trimethylbenzene and, to a lesser extent,
trimethylcyclohexane. These data suggest that these two compounds may be capable
of the induction of their own metabolic conversion (Zahlsen et al. 1990).
2.3.2.2 Oral Exposure
No studies were located regarding distribution following oral exposure to Stoddard solvent in humans
or animals.
2.3.2.3 Dermal Exposure
No studies were located regarding distribution following dermal exposure to Stoddard solvent in
humans or animals.
2.3.3 Metabolism
Men who were exposed to a mist of a specific type of Finnish white spirits used for washing cars
(Pfaffli et al. 1985) had elevated levels of dimethylbenzoic acid, a metabolite of trimethylbenzene, in
their urine following the workshift. This study attempted to quantify exposure to white spirits through
the analysis of dimethylbenzoic acid isomers, which are easily detected markers. It assumed that being
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in a mixture does not affect the metabolism of trimethylbenzene or any of the other constituents of
Stoddard solvent The amount excreted was linearly related to the estimated exposure level. The
composition of the white spirits in this study included 11% aromatics with 1% trimethylbenzene
isomers, which is similar to the compositions of Stoddard solvent used in the United States. A
correlation between exposure to 1,2,4-trimethylbenzene, a component of white spirits, at the TLV-TWA (25 ppm), 
and the urinary concentration of 3,4-dimethylhippuric acid (3/4-DMHA) was reported in ceramics workers 
(Fukaya et al.1994). Rats were dosed by gavage with t-butylcyclohexane (800 mg/kg), another component 
of white spirits, andseven compounds were identified as urinary metabolites (Henningsen et al. 1987). The
 primary metabolite was trans-4-t-butylcyclohenanol, with lesser amounts of 2c-hydroxy-4t-t-butylcyclohexanol, 
2-methyl-2-cyclohexylpropanoic acid,2c-hydroxy-4c-t-butylcyclohexanol, 2-methyl-2-cyclohexyl-1,3-propanediol, 
2t-hydroxy-4t-butylcyclohexanol, and Cis-4-t-butylcyclohexanol also being detected. Rats that had a 
white spirit formulation (690.8 mg/kg) applied to their tails 5 days/week for 6 weeks were reported to have 
excreted several products (dimethylbenzoic acid isomers) of trimethylbenzene metabolism in their urine.
2.3.4 Excretion
2.3.4.1 Inhalation Exposure
No studies were located regarding excretion of Stoddard solvent following inhalation exposure in
humans or animals. It is expected that components or metabolites of Stoddard solvent that are volatile
but have low solubility in the blood, would be rapidly exhaled from the lungs. Like absorption, this
process is governed by blood/gas solubility ratios (Klaassen 1991). Components with low blood/gas
ratios would be most rapidly excreted from the lungs because of their low blood solubility, while those
with high blood/gas solubility ratios would be eliminated less efficiently by the lungs due to their high
blood solubility; this situation is exactly the reverse of that for inhalation absorption (Klaassen 1991).
The aromatic hydrocarbons are expected to be excreted primarily in the urine (Klaassen 1991).
2.3.4.2 Oral Exposure
No studies were located regarding excretion of Stoddard solvent following oral exposure in humans or
animals. It is expected that the poorly absorbed components of Stoddard solvent would continue




No studies were located regarding excretion of Stoddard solvent following dermal exposure in humans.  Rats exposed
to daily applications of white spirits (absorbed dose of 690.8 mg/kg) on the tail for 6 weeks excreted dimethylbenzoic
acid isomers (2,3-, 2,4-, 2,5-, 3,4-, 3,5-dimethylbenzoic acid) in the urine (Verkkala et al. 1984). No other metabolic
parameters have been measured.
2.3.5 Mechanisms of Action
Little is known regarding the specific mechanisms of action by which Stoddard solvent exerts its toxic
effects. Generally, it is believed that the aromatic components of Stoddard solvent would be more
readily and completely absorbed through the lungs and skin than would long-chained aliphatic
components. The mechanism of action of Stoddard solvent on the central nervous system is not
known. Exposure to white spirit increased levels of the neurotransmitters noradrenaline, dopamine,
and 5-hydroxytryptamine in the brain of exposed rats, although the biological significance of these
changes is not understood (Lam et al. 1992). Stoddard solvent does not contain the shorter chain
alkanes that have been known to cause anesthesia (Haydon et al. 1977). Inhalation exposure of rats to
white spirits for 3 weeks (6 hours/day, 7 days/week) resulted in a significant increase in the rate of
reactive oxygen species (ROS) generation in the hippocampus (Lam et al. 1994). Since the brain
contains large amounts of polyunsaturated fatty acids, proteins, and catecholamines, all of which are
targets for ROS, increased rates of ROS in the brain following white spirit exposure might provide
evidence that the mechanism for neurotoxicity involves ROS interaction with lipid peroxidation,
protein oxidation, and DNA (Lam et al. 1994).
Although renal toxicity has been reported after exposure to Stoddard solvent in rats, it has not been
reported in humans, rabbits, guinea pigs, dogs, or monkeys. A mechanism of action has been
proposed for the renal effects observed in male rats. The carrier protein α2µ-globulin is synthesized in
large quantities by these animals and is used to transport pheromones into the urine (Boeskei et al.
1992). After glomerular filtration with their ligand, these carrier proteins are resorbed in massive
quantities in the PZ section of the proximal convoluted tubule and catabolized in lysosomes (EPA
1991a; Kimura et al. 1991a). It is proposed that Stoddard solvent exerts its toxic effect by binding to
α2µ-globulin; after resorption in the proximal tubule, it is believed to accumulate in lysosomes, where
it resists degradation and causes the pathological changes that characterize α2µ-globulin nephropathy
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syndrome. Since synthesis of the carrier protein, α2µ-globulin, is under androgenic control, this
hypothesis would explain why neither female rats nor castrated male rats have been found to be
afflicted with α2µ-globulin nephropathy. A more detailed discussion of this mechanism can be found
in Section 2.2.1.2.
Humans are not believed to be susceptible to proximal tubule damage by the mechanism, since they do not produce the
α2µ-globulin protein. Analogous human proteins could possibly undergo the same
interactions as α2µ-globulin if they were produced in similar quantities. But because humans are not
known to synthesize and resorb other lipocalin proteins in such massive quantities as rats do with
α2µ-globulin, it is unlikely that Stoddard solvent would cause such profound toxicity if an interaction
did occur. No reports were located that show proximal tubule damage in persons exposed to Stoddard solvent.
Epidemiology studies of persons with glomerulonephritis showed no differences in exposure
to organic solvents between cases and controls (van der kaan 1980), and patients exposed to white
spirits exhibited normal renal function (Flodin et al. 1984). However, one case study of a man
chronically exposed to Stoddard solvent reported the development of glomerulonephritis (Daniell et al.1988). This
case is discussed more fully in Section 2.3.2. Thus, it is possible that there may be other
mechanisms of action for renal toxicity in humans.
2.4 RELEVANCE TO PUBLIC HEALTH
Very little information is available on the effects other than neurotoxicity of Stoddard solvent on
humans and animals. No studies have been performed regarding oral exposure in humans or animals.
Most of the toxicological investigations of Stoddard solvent have focused on inhalation exposures. In
almost all cases, it was completely vaporized. Although Stoddard solvent as a whole is relatively
volatile, most human exposure scenarios are likely to result in greater exposure to the more volatile
fractions, including the aromatics, than to the less volatile components. If a significant amount of
toxicity is due to the less volatile fractions, the studies using completely vaporized Stoddard solvent
may exaggerate the effects expected when extrapolated to more realistic human exposuresituations.
On the other hand, if most of the toxicity is due to the more volatile components, and substituted
aromatics and naphthalenes do tend to be more toxic than alkanes in general, then the complete
vaporization experiments may fairly accurately represent the effects from exposure to Stoddard solvent fumes.
 In the absence of other data, it is reasonable to extrapolate human risk from these inhalation
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exposure studies to completely vaporized Stoddard solvent. It is likely that most exposure at
hazardous waste sites would occur to the vapor of Stoddard solvent.
The effects that are the most likely to occur following inhalation or dermal exposure are neurological
effects, which are discussed below. Adverse respiratory effects have been seen in a few animal
studies, although the reliability of the findings in some of the studies is questionable because of similar 
adversefindings in the controls. Adverse respiratory effects have not been seen in humans. It is 
possible that aspiration ofStoddard solvent may result in pneumonitis, assuming that the Stoddard
solvent acts in a manner similar to the related mixture, kerosene. The reports on developmental and
reproductive effects are minimal and negative. Evidence of genotoxicity is generally negative. The
evidence of carcinogenicity is negative in humans. However, positive findings of squamous cell
carcinomas were reported in one mouse study. Conclusions specific to Stoddard solvent are limited
because the study tested a rust-preventive compound that consists of  90% Stoddard solvent, 7%
calcium petroleum sulfonate, and 3% ethylene glycol monobutyl ether. However, the data identify a
potential area of concern.
Minimal Risk Levels for Stoddard Solvent
An MRL could not be derived for acute inhalation exposure (14 days or less) to Stoddard solvent.
The best study in the acute database was a no-observed-adverse-effect level (NOAEL) at a time
weighted average of 1,560 mg/m3 in sedentary male human volunteers exposed to completely
vaporized white spirits for 2 hours. This study was not suitable for MRL derivation because the
results from a 2-hour exposure could not be reliably extrapolated to a continuous 14-day exposure.  These
humans showed no neurological effects from exposure to the white spirits (presumably the 83% aliphatic,
17% aromatic components described in Astrand et al. 1975) (Gamberale et al. 1975). In this study,
central nervous system function was evaluated in multiple tests including perceptual speed, simple
reaction time, short-term memory, numerical ability, and manual dexterity. A lowest-observed-adverse-effect
level (LOAEL) was seen in the same study when humans were exposed to 4,000 mg/m3 for 50 minutes. The subjects
had a prolonged simple reaction time compared to control results in the same volunteers during a non-exposure 
period.It should be noted that because of practical constraints, these tests were conducted on volunteers at rest and 
that parallel pharmacokinetic studies have demonstrated greater uptake during exercise (Astrand et al. 1975).
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There were no human or animal studies suitable for developing MRLs for intermediate- or chronicduration
exposures to Stoddard solvent in the air. However, more serious health effects would be predicted with longer
 duration exposure. There are no oral studies in either humans or animals. The dermal effects in humans and
animals are skin irritation and possible neurological effects, but amethodology for developing MRLs based on
dermal exposure is not available.
Death. There is no reliable information regarding doses of Stoddard solvent that could cause death in humans.
It is possible that exposure to very high concentrations of this petroleum distillate could pose a serious health
hazard and possibly even cause death from central nervous system depression. However, death is unlikely un-
less there is an extremely high exposure, since Stoddard solvent contains very little of the smaller carbon
chains (C8 and below) which are known to be highly volatile and highly toxic (Andrews and Snyder 1986).
There is also a remote risk of death due to pulmonary pathology from aspiration (Ellenhorn and Barceloux 1988).
Levels that may pose a mortality risk to humans are not known and cannot be determined from animal studies.
Concentrations of 10,000 mg/m3 Stoddard solvent were lethal to cats (Carpenter et al. 4975a, 1975b), and death
From unexplained causes was noted in guinea pigs exposed for 90 days to 363 and 892 mg/m3 vaporized
mineral spirits (Jenkins et al. 1971; Rector et al. 1966). Nonlethal levels were reported for rats, rabbits, dogs, and
monkeys following a continuous exposure for 90 days to 1,271 mg/m3 vaporized mineral spirits; for guinea pigs,
rats, rabbits, dogs, or monkeys following repeated, 6-week intermediate exposure to 1,353 mg/m3 mineral spirits;
and for rats following acute exposures of up to 8,200 mg/m3 of completely vaporized Stoddard solvent (Carpenter
et al. 1975a, 1975b; Rector et al. 1966).
Systemic Effects. There is very little information on the health effects of Stoddard solvent in either
humans or animals. There was a lack of gastrointestinal, musculoskeletal, hepatic, and renal effects in
a laboratory experiment in humans exposed to 610 mg/m3 of Stoddard solvent in the air for 6 hours
(Pedersen and Cohr 1984a). Possible indications of musculoskeletal effects were noted, however, as
increased creatinine kinase levels after an exposure to 616 mg/m3 of vaporized white spirits (99%
alkanes, no aromatics) (Pedersen and Cohr 1984b).
Respiratory Effects. It is possible that Stoddard solvent would adversely affect the lungs. There are
two human studies on respiratory effects. One found no change in respiratory rate from a 30-minute
exposure to 2,400 mg/m3 (Hastings et al. 1984), and the other found no adverse effects on respiratory
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function in men exposed to paint solvents in the air for 4-42 years (Hane et al. 1977). The data on
respiratory effects in animals are limited but show upper respiratory irritant effects in rats from acute
exposure (Carpenter et al. 1975a, 1975b; Riley et al. 1984) and decreased respiratory rate in mice
(Carpenter et al. 1975a, 1975b). No evidence of lung effects was found following acute exposures.
However, congestion, bronchitis, and mixed inflammatory cell infiltration were noted in rats, rabbits,
guinea pigs, dogs, and monkeys exposed to vaporized mineral spirits at 1,271 mg/m3 for 90 days
(Rector et al. 1966). Also, guinea pigs exposed to concentrations of 1,353 mg/m3 exhibited pulmonary
congestion and emphysema from intermediate exposures for 6 weeks (Rector et al. 1966). However,
the data for rabbits, dogs, and monkeys are limited by the use of three animals or less. Based on
information from other petroleum distillates, for instance, kerosene, it is possible that if  Stoddard
solvent is taken into the mouth, it woulid be aspirated into the lungs and might then cause pneumonitis
(Coruh and Inal 1966; Majeed et al. 1981; Nouri and Al-Rahim 1970). Exposure of rats to 214 mg/m3
of white spirits for 4 days caused loss of cilia and squamous metaplasia in the trachea and nasal cavity
(Riley et al. 1984). However, the study was limited by use of only one dose group in addition to the
controls. No other significant adverse respiratory effects were seen in other animal studies (Carpenter
et al. 1975a, 1975b; Rector et al. 1966).
Cardiovascular Effects. No compound-related changes in cardiovascular parameters were noted after
men were exposed to up to 2,500 mg/m3 of vaporized mineral spirits for a 30-minute period (Astrand
et al. 1975), and no changes in blood pressure were noted in painters exposed for 4-42 years to paints
and solvents (Hane et al. 1977). No histopathological changes were noted in the hearts of rats, rabbits,
guinea pigs, dogs, or monkeys exposed to 1,271 mg/m3 of vaporized mineral spirits for an
intermediate-duration exposure (Rector et al. 1966). Although Stoddard solvent exposure does not
appear to cause any effect on the cardiovascular system, sufficient data do not exist to make an
unequivocal determination.
Gastrointestinal Effects. No adverse gastrointestinal effects were noted after inhalation of 610 mg/m3
vaporized white spirits by human volunteers for 6 hours (Pedersen and Cohr 1984a), andnausea was
reported in one of nine workers exposed to Stoddard solvent when cleaning machines (Larsen and
Schmunes 1974). No studies were located regarding gastrointestinal effects in animals after inhalation
exposure to Stoddard solvent. While it appears that Stoddard solvent might cause nausea in certain
individuals, sufficient data do not exist to make an unequivocal determination regarding gastrointestinal effects.
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Hematological Effects. Studies of house painters and car repair workers exposed to mixed solvents
have shown decreased red blood cell counts and hemoglobin concentrations as well as increased mean
erythrocyte and platelet volumes in these workers (Beving et al. 1991; Hane et al. 1977). However,
normal hematological values were noted in 128 persons exposed to a variety of solvents including
white spirits (Flodin et al. 1984) and, in other case reports, and no causal relationship could be
established between persons with aplastic anemia and exposure to Stoddard solvent (Prager and Peters
1970; Scott et al. 1959). Normal leukocyte, hemoglobin, and hematocrit levels were found in rats,
rabbits, guinea pigs, dogs, and monkeys exposed to up to 1,353 mg/m3 of vaporized mineral spirits for
6 weeks or to 1,271 mg/m3 for 90 days (Rector et al. 1966) or in rats and dogs exposed to
1,900 mg/m3 of vaporized Stoddard solvent for 13 weeks (Carpenter et al. 1975a, 1975b). Since there
are hmited and conflicting data regarding the hematological effects of exposure to Stoddard solvent, an unequavocal
conclusion about these end points cannot be made.
Musculoskeletal Effects. The only indicator of musculoskeletal compromise was an increase in
creatine kinase after exposure of human volunteers to 616 mg/m3 of vaporized white spirits for 5 days
(Pedersen and Cohr 1984b). No changes in serum creatine kinase was noted after exposure of
volunteers to 610 mg/m3 for one 6-hour period (Pedersen and Cohr 1984a). Rats that were exposed to
2,290 mg/m3 or 4,580 mg/m3 white spirits showed increases in serum creatinine, but no dose response
was evident (Ostergaard et al. 1993). Although Stoddard solvent exposure does not appear to cause
any musculoskeletal effects, sufficient data do not exist to make an unequivocal determination.
Hepatic Effects. The few available studies regarding hepatic effects indicate that acute, low-level
exposures to Stoddard solvent have very minor, if any, effects on liver function. Men exposed to
610 mg/m3 for 6 hours showed no changes in serum liver products (Pedersen and Cohr 1984a).
Painters exposed to white spirits and other solvents for chronic periods showed elevated levels of
serum alanine aminotransferase but had normal liver biopsies (Dossing et al. 1983). Persons exposed
to a variety of solvents, including white spirits, showed elevated glutamyl transferase levels (Flodin et
al. 1984). A group of painters showed normal serum transaminase levels compared to unexposed
controls (Hane et al. 1977). No histopathological or blood chemical indicators of liver damage were
noted in guinea pigs exposed to up to 1,271 mg/m3 of vaporized white spirits for 90 days (Jenkins et
al. 1971; Rector et al. 1966), in rats or guinea pigs exposed to 1,353 mg/m3 for 6 weeks (Rector et al.




Renal Effects. Although no human studies have reported renal toxicity that could be attributed to
Stoddard solvent, several investigations have reported proximal tubule damage in male rats. A number
of the observed renal effects of Stoddard solvent are consistent with a mechanism which appears to be
unique to male rats. Male rodents scent mark their territories with pheromones secreted in the urine.
These pheromones are transported to the urine by low molecular weight serum binding proteins which
are members of the lipocalin family (Bocskei et al. 1992). In male rats, the carrier protein is
α2µ-globulin, which is synthesized in large quantities in the liver (Bocskei et al. 1992). X-ray
crystallography has demonstrated that α2µ-globulin is a tetramer which has a doughnut hole in the
center for transport of the ligand (Bocskei et al. 1992). Although the preferred pheromone ligand for
the analogous dimeric mouse protein, mouse urinary protein, has been identified through x-ray
crystallography of the bound complex, the particular pheromone with the best fit to the α2µ-globulin
tetramer has not yet been identified (Bocskei et al. 1992). After glomerular filtration with their ligand,
these carrier proteins are resorbed in massive amounts in the P2 section of the proximal renal tubule
and then catabolized in lysosomes (EPA 1991a; Kimura et al. 1994a).
Unfortunately, the α2µ-globulin tetramer seems to be proficient at transporting other hydrophobic
molecules besides pheromones through the blood and into the urine. Other substances which
apparently also bind to this carrier protein include a number of hydrophobic xenobiotics such as
petroleum-derived hydrocarbons or their constituents or metabolites, including decalin and the gasoline
constituent trimethylpentane (EPA 1991a). The xenobiotic-α2µ-globulin complex is then reabsorbed in the
proximal tubule and accumulates in lysosomes where it resists degradation. Accumulation of this complex
is thought to trigger pathological responses within the kidney. This α2µ-globulin nephropathy syndrome is
characterized by the following lesions (Alden 1986; EPA 1991a; Short et al. 1987): excessive accumulation
of hyaline droplets in the P2 segment of the proximal tubule region of thekidney; association of the hyaline
droplets with the protein α2µ-globulin; single cell necrosis in the P2 segment epithelium and exfoliation of
these degenerated cells; sustained regenerative tubule cell proliferation, often with tubular dilation and tubular
epithelial necrosis; accumulation of granular casts formed from the-cellular debris and subsequent tubule
dilation at the junction of the P3 segment and the thin loop of Henle; linear mineralization of the renal papillar
tubules with hyperplasia of the renal pelvic urothelium.
The hepatic synthesis of α2µ-globulin is under androgenic control, and the protein is found at
concentrations 100-300 times higher in male rat urine than in female rat urine (Shapiro and
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Sachchidananda 1982; Van Doren et al. 1983). Neither female rats nor castrated male rats show the
characteristic renal pathology associated with α2µ-globulin nephropathy. Aging male rats show chronic progressive
nephropathy symptoms that are similar to α2µ-globulin nephropathy, so it is important to run concurrent controls when
assessing renal toxicity. α2µ-Globulin is not present in other rodents, but mice have a similar pheromone carrier, mouse
urinary protein, which does not cause the same effects.  Although other members of the lipocalin protein family do
occur in nonrodent species, including humans, they are not produced in such massive quantities, and these species do
not exhibit renal toxicity in response to the same set of substances that produce this characteristic toxicity in male rats
(Swenberg et al. 1989).
The data discussed above suggest an α2µ-globulin interaction as the mechanism for Stoddard solventinduced
nephrotoxicity in the rat. The renal toxicity seems to be androgen dependent since it does not occur in female rats and
is absent or greatly attenuated in castrated male rats, which only have residual levels of α2µ-globulin left (Borghoff et
al. 1990). The pathological sequence is consistent with α2µ-globulin nephropathy. Hyaline droplets enclosed in
isosomes are increased in number and size in the P2 section of the proximal renal tubule; however, no
immunohistochemistry has been done to confirm that the protein in these droplets is actually α2µ-globulin, although the
levels of this protein are elevated in the kidney as a whole in symptomatic exposed male rats (Viau et al. 1986). The
fact that similar petroleum distillate mixtures and alkanes seem to cause renal toxicity via α2µ-globulin
interactions increases the plausibility that Stoddard solvent also acts via the same mechanism.
There are two respects in which the data on the renal toxicity of Stoddard solvent are less than ideal.
First, not all the studies mentioned above used complete Stoddard solvent; several focused on the
predominant alkane components, so the potential contributions of the aromatic constituents have not
been as well tested. A second question is whether all the renal toxicity observed is due to interactions
with α2µ-globulin or whether simultaneous kidney damage by another subset of components via other
mechanisms could have been overlooked. The urinary enzyme activity ratios suggesting distal tubule
damage (Viau et al. 1986) raise some doubts in this category since α2µ-globulin -induced damage is
typically confined to the proximal tubule.
Glomerulonephritis has also been raised as a possible renal effect due to Stoddard solvent exposure,
but the evidence is equivocal. A case-control study showed a significantly greater exposure of patients
with glomerulonephritis to petroleum products (Yaqoob et al. 1992). Another case-control study of
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patients with end-stage renal failure showed that approximately 60% of those with glomerulonephritis
had significant exposure to hydrocarbons compared with 25% of patients with nonglomerulonephritis
renal failure (Finn et al. 1980); however, the use of hospital inpatients as the control group rather than
employed workers may have biased this study toward a positive outcome (Phillips 1984). In both of
these studies, however, patients may have been exposed to multiple hydrocarbon products. A patient
with glomerulonephritis who was exposed to Stoddard solvent by both inhalation and dermal contact
up to 6 hours/day for a year was reported by Daniel1 et al. (1988). However, both another case report
and a case-control study showed no increase in glomerulonephritis with organic solvent exposure
(Flodin et al. 1984; van der Laan 1980). A review of the literature (Bombassei and Kaplan 1992)
identified a number of other studies claiming an association between hydrocarbon exposure and antiglomerular
basement membrane antibody-mediated disease (Goodpasture’s syndrome) or other types of glomerulonephritis.
If all the renal damage caused by Stoddard solvent in rats is due to α2µ-globulin interactions, then it
probably does not pose a large risk of nephrotoxicity to humans. Since humans do not have
α2µ-globulin, the issue becomes whether analogous human proteins could possibly undergo the same
interactions as α2µ-globulin if they were produced in similar quantities. Because humans are not
known to synthesize and resorb other lipocalin proteins in such massive quantities as rats do with
α2µ-globulin, it is unlikely that Stoddard solvent would cause such remarkable toxicity even if an
interaction did occur (Olson 1990). To completely dismiss the possibility of human risk, members of
the human lipocalin family which are filtered and resorbed in the kidney could be assayed to
determine their ability to bind similar xenobiotics or metabolites and whether this binding inhibited
catabolism. Since the renal damage may be exclusive to male rats, no human MRLs have been
derived from data regarding this end point.
Dermal Effects. Dermal irritation is an effect that has been reported after exposure to Stoddard
solvent. Case studies in humans (Nethercott et al. 1980) and experimental studies in guinea pigs
(Anderson et al.-1986) indicate that skin irritation can occur following acute dermal exposure. Other
petroleum distillates, such as kerosene (Annobil 1988; Mosconi et al. 1988; Tagami and Ogino 1973)
or gasoline (Beck et al. 1983; Vernot et al. 1990), are also known to cause skin irritation.
Ocular Effects. Eye irritation is another possible effect of exposure to Stoddard solvent.
Experimental studies in humans have indicated that eye irritation may be induced by Stoddard solvent
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vapors through direct contact at concentrations of 2,700 mg/m3 (Carpenter et al. 1975a, 1975b) and
2,400 mg/m3  (Hastings et al. 1984).
Body Weight Effects. Although no human studies were located regarding body weight changes,
studies in rats, rabbits, guinea pigs, monkeys, and dogs exposed by inhalation to Stoddard solvent or
mineral spirits for intermediate durations were found to have normal body weight gain (Carpenter et
al. 1975a, 1975b; Rector et al. 1966). One study, in which rats were exposed to white spirits
(4,580 mg/m3) for 6 months, did report decreased body weight, but the change was not quantified
(Ostergaard et al. 1993). Although Stoddard solvent exposure does not appear to cause any effect on
body weight, sufficient data do not exist to make an unequivocal determination.
Immunological and Lymphoreticular Effects. There is only one human study on immunological effects available, and
it reported no adverse effects on immunoglobulin levels when men were exposed to 616 mg/m3 of white spirits (99%
alkanes) in the air for 6 hours/day over a 5-day period (Pedersen and Cohr 1984b). However, it is possible that
Stoddard solvent may affect the immune system in ways that cannot be measured by this type of test. No animal
studies are available. No immunological data regarding the aromatic components of Stoddard solvent were located.
Therefore, the effects induced by these components could not be determined.
Neurological Effects. Acute inhalation exposure to Stoddard solvent or white spirits has caused
nervous system effects. A NOAEL was seen in sedentary male humans exposed to a time-weighted
average of 1,563 mg/m3 of completely vaporized white spirits for 2 hours (Gamberale et al. 1975).
These humans showed no neurological effects from exposure to the white spirits (presumably the 83%
aliphatic, 17% aromatic components described in Astrand et al. 1975) (Gamberale et al. 1975). In this
study, central nervous system function was evaluated in multiple tests including perceptual speed,
simple reaction time, short-term memory, numerical ability, and manual dexterity. A lowest-observedadverse-effect
level (LOAEL) was seen in the same study when humans were exposed to 4,000 mg/m3 for 50 minutes. The subjects
had a prolonged simple reaction time compared to controlresults in the same volunteers during a non-exposure period.
It should be noted that because of practical constraints, these tests were conducted on volunteers at rest and that
parallel pharmacokinetic studies have demonstrated greater uptake during exercise (Astrand et al. 1975).
STODDARD SOLVENT  61
2. HEALTH EFFECTS
Other studies support the hypothesis that the central nervous system (CNS) is the most sensitive target
for acute exposure to Stoddard solvent. Several of these studies involve effects on central nervous
system-mediated motor coordination. For example, in one human study (Hastings et al. 1984), male
volunteers were exposed for 30 minutes to completely vaporized Stoddard solvent at 0, 600, 1,200,
1,800, and 2,400 mg/m3. CNS/motor function was tested in three ways, through eye-hand
coordination, reaction time/decision making, and video game visual-motor skill/eye-hand coordination
challenges. When results during all exposures were compared to pre- and post-exposure control
performances, there was a statistically significant difference for both the eye-hand coordination test
and the video game visumotor test. However, this difference was due to impairment only at 600
mg/m3; the results at other exposure levels did not differ from the controls. Since the putative effect
seen at 600 mg/m3 was not observed at the higher doses, 2,400 mg/m3 was considered to be the
tentative level at which no effect was observed. Another human volunteer study of 12 males showed
no changes in subjective symptoms such as headache, dizziness, visual disturbances, tremor, muscle
weakness, incoordination, or skin paraesthesia, as determined by a questionnaire on subjective
symptoms after a 6-hour exposure to 610 mg/m3 of Varnoline or two other white spirit formulations
(Pedersen and Cohr 1984a). This questionnaire on subjective experiences is only a crude indicator of
central nervous system effects compared to the more sensitive functional tests used in the Gamberale
et al. (1975) study. In a test of human volunteers, two out of six reported slight dizziness after a 15-
minute exposure to 2,700 mg/m3 (Carpenter et al. 1975a, 1975b). In rats, a slight coordination loss
after an 8-hour exposure to 8,200 mg/m3, but not to 4,600 mg/m3, was observed (Carpenter et al.
1975a, 1975b). Since the incoordination was seen during cage-side observation, rather than in more
sensitive functional tests, it is not surprising that the effect is not seen until a somewhat higher
integrated concentration is administered than that in the Gamberale et al. (1975) study. Furthermore,
much higher acute inhalation doses have caused much more blatant nervous system effects.
Cerebral atrophy, discoordination, dementia, headaches, memory deficits, and fatigue were reported in
humans from chronic exposure to several solvents, including Stoddard solvent (Daniel1 et al. 1988;
Flodin et al. 1984; Gregersen et al. 1984; Hane et al. 1977; Mikkelsen et al. 1988; Olson.1982).
These chronic effects may or may not be due to Stoddard solvent since other chemicals were also
present during exposure; however, these data imply that effects become more severe with prolonged
exposure time. No data are available for neurological effects from oral exposure. Similar neurological
effects have also been found in humans following combined dermal and inhalation exposure to
solvents which may include Stoddard solvent. Stoddard solvent does not contain the short-chained
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alkanes that are known to cause anesthesia (Haydon et al. 1977). Mice exposed to propylbenzene, a
component of Stoddard solvent, at 2,000-8,000 ppm for 20 minutes showed a range of
neurobehavioral effects including a loss of righting reflex, decreased arousal, and reaction to sensory
stimuli and psychomotor impairment (Tegeris and Balster 1944). Other solvents and petroleum
distillates with longer carbon chains, such as fuel oils, have been known to cause more severe central
nervous system depression than that observed with Stoddard solvent (Kainz and White 1984; Knave et
al. 1978; Porter 1990).
Reproductive Effects. Men exposed to white spirits (composition, 99% alkanes) in the air (616 mg/m3
for 30 minutes) had slightly (9-11%) decreased (p<0.05) serum levels of folliclestimulating hormone
(Pedersen and Cohr 1984b). The possible reproductive outcome of this change isnot known. Another
study shows that men who were occupationally exposed for 1-17 years to Stoddard solvent in the air
had normal sperm counts, motility, and morphology (Tuohimaa and Wichmann 1981). This study had
several limitations including a small test population, the degree of accuracy of the exposure assessment,
exposure to mixed solvents, and variability of sperm parameters. There were no data regarding reproductive
effects in animals. It is not possible to draw conclusions from the available data regarding the possible
reproductive effects of Stoddard solvent on persons exposed at hazardous waste sites.
Developmental Effects. No human studies on developmental effects from Stoddard solvent
exposure are available for any route of exposure. Stoddard solvent vapor did not cause maternal
toxicity, structural teratogenesis, or decreased fetal weight when administered during organogenesis in
the rat, although some skeletal variations did occur (API 1977). Certain other petroleum distillates
(gasoline or fuel oils) have also shown very few adverse developmental effects (API 1979a, 1979b;
Beliles and Mecler 1983; API 1978).
Genotoxic Effects. No genotoxicity studies were located regarding in vivo human exposure to
Stoddard solvent. However, one in vitro study was located in which human peripheral lymphocytes
were incubated in the presence of white spirits (a petroleum distillate composed of 85% aliphatic and
15% aromatic hydrocarbons and also referred to as Stoddard solvent), in four different white
spirits/ethanol dilutions, and investigated for increased sister chromatid exchange. Two incubation
periods were employed for each concentration: 1 hour and 24 hours. No significant increase in sister
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chromatid exchange frequency was observed for any concentration at either incubation period (Gochet
et al. 1984). Refer to Table 2-3 for a further summary of these results.
In vivo animal studies involving either Stoddard solvent or white spirits provide no evidence of
genotoxicity. Neither inhaled (50 mg/m3 in five periods of 5 minutes each, separated by 5-minute noexposure
intervals) nor intraperitoneal (0.1, 0.05, or 0.01 mL) doses of white spirits produced a
significant increase in micronuclei in mouse bone marrow (Gochet et al. 1984). Rats given 0.087,
0.289, or 0.868 mL/kg Stoddard solvent intraperitoneally were negative for chromosomal aberrations in bone marrow
cells; the Stoddard solvent used for the study contained 18.9% aromatic hydrocarbons
(see Table 3-3, Stoddard solvent, for a further analysis of the composition) (API 1978a; Conaway et
al. 1984). In a dominant lethal study, mice were dosed subcutaneously and rats intraperitoneally with
1.0 mL/kg Stoddard solvent (API 1982). Fifteen males of each species were allowed to mate with two
or three females per week for one complete sperm cycle (8 weeks for mice and 10 weeks for rats).
The rat pregnancy index was significantly lower than the corresponding control for the 1st week only;
otherwise, the results for both species were negative (API 1982). Refer to Table 2-3 for a further
summary of these results.
In vitro tests using Salmonella typhimurium (API 1978a; Conaway et al. 1984; Gochet et al. 1984) and
mouse L5178Y lymphoma cells (API 1978a, 1987b; Conaway et al. 1984) to screen for gene
mutations support the negative results observed in the mammalian in vivo and human in vitro studies
mentioned above. One mouse L5178Y gene study does report significant mutation frequencies at high
doses (50-60 nL/mL for nonactivation and 60-80 nL/mL for activation); however, these results are
equivocal because the same doses were highly cytotoxic (API 198713). Please refer to Table 2-4 for a
further summary of these results. Based on the available genotoxicity data, Stoddard solvent and white
spirits do not appear to pose a genotoxic threat in animals. However, the available data are much too
scant to allow for definitive conclusions regarding the genotoxicity of Stoddard solvent/white spirits in
humans.
Concerns have been raised about the genotoxicity of the individual components of Stoddard solvent.
Frequency of mutations induced by methylazoxymethanol (MAM), a complete carcinogen in several
species, was increased (p<0.05) in V79 Chinese hamster cells by n-decane, while treatment with this





promoter. Further study is needed to determine whether the effects observed with individual
components would also occur in the Stoddard solvent mixture.
Cancer. There is one chronic inhalation exposure study of humans (Siemiatycki et al. 1987), which
presented epidemiological data that reported an odds ratio greater than 1 for prostate cancer, Hodgkin’s lymphoma,
and squamous cell carcinoma of the lung. However, the study was limited due to exposure to mixed substances and an
arbitrary statistical selection criteria for analysis. A mouse skin-painting study (EPA 1984c) demonstrated
carcinogenesis using a mixture containing 90% Stoddard solvent, 7% calcium petroleum sulfonate, and 3% ethylene
glycol monobutyl ether. This study indicates an area of potential concern, even though the carcinogenesis cannot be
attributed to a particular component.  Thus, neither study provides conclusive results on the carcinogenic potential of
Stoddard solvent for humans exposed at hazardous waste sites. A test using Stoddard solvent alone is needed to verify
whether the findings of EPA 1984c can be attributed to Stoddard solvent.
It is also possible that the skin irritant effects of Stoddard solvent could have contributed to the
promotion of effects initiated by other components of the mixture. The alkylbenzenes present in
Stoddard solvent are not believed to be carcinogenic, based upon negative or weakly positive
genotoxicity test results (Andrews and Snyder 1991). However, further animal testing is needed to
confirm a lack of carcinogenicity. A dermal study in mice showed that dodecane was a tumor
promotor (Site 1966). Benzo[a]pyrene and benzo[a]anthracene were reported to be 1,000 times more
potent in producing tumors when dodecane was used as a diluent than when it was not used (Bingham
and Falk 1969).
Promotion activity of n-dodecane was also demonstrated in dermal tests using Swiss mice, although
dermal carcinogenicity tests were negative (Saffiotti and Shubic 1963). Decane was reported to
enhance the carcinogenicity of benzo[a]pyrene after application to mouse skin (Van Duuren and
Goldschmidt 1976). Several studies have shown that some n-alkane components of Stoddard solvent
are promoters of carcinogenicity (Site 1966; Saffioti and Shubik 1965; Van Duuren and-Goldschmidt
1976). Other studies raise questions about whether some of the n-alkane components may also be
cocarcinogens (Bingham and Falk 1969; Horten et al. 1957, 1966, 1976; Van Duuren and Goldschmidt 1976). Further




There are no existing national guidelines concerning potential carcinogenicity that specifically pertain
to Stoddard solvent. The International Agency for Research on Cancer (IARC) has determined that
some petroleum distillates are probably carcinogenic to humans for occupational exposure in petroleum refining
(IARC 1989); however, petroleum solvents as a group have not yet been evaluated.
2.5 BIOMARKERS OF EXPOSURE AND EFFECT
Biomarkers are broadly defined as indicators signaling events in biologic systems or samples. They
have been classified as markers of exposure, markers of effect, and markers of susceptibility
(NAS/NRC 1989).
A biomarker of exposure is a xenobiotic substance or its metabolite(s) or the product of an interaction
between a xenobiotic agent and some target molecule(s) or cell(s) that is measured within a
compartment of an organism (NAS/NRC 1989). The preferred biomarkers of exposure are generally
the substance itself or substance-specific metabolites in readily obtainable body fluid(s) or excreta.
However, several factors can confound the use and interpretation of biomarkers of exposure. The
body burden of a substance may be the result of exposures from more than one source. The substance
being measured may be a metabolite of another xenobiotic substance (e.g., high urinary levels of
phenol can result from exposure to several different aromatic compounds). Depending on the
properties of the substance (e.g., biologic half-life) and environmental conditions (e.g., duration and
route of exposure), the substance and all of its metabolites may have left the body by the time biologic
samples can be taken. It may be difficult to identify individuals exposed to hazardous substances that
are commonly found in body tissues and fluids (e.g., essential mineral nutrients such as copper, zinc,
and selenium). Biomarkers of exposure to Stoddard solvent are discussed in Section 2.5.1.
Biomarkers of effect are defined as any measurable biochemical, physiologic, or other alteration within an organism
that, depending on magnitude, can be recognized as an established or potential health impairment or disease
(NAS/NRC 1989). This definition encompasses biochemical or cellular signals of tissue dysfunction (e.g., increased
liver enzyme activity or pathologic changes in female genital epithelial cells), as well as physiologic signs of
dysfunction such as increased blood pressure or decreased lung capacity. Note that these markers are often not
substance specific. They also may not be directly adverse, but can indicate potential health impairment (e.g., DNA
adducts). Biomarkers of effects caused by Stoddard solvent are discussed in Section 2.5.2.
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A biomarker of susceptibility is an indicator of an inherent or acquired limitation of an organism’s
ability to respond to the challenge of exposure to a specific xenobiotic substance. It can be an
intrinsic genetic or other characteristic or a preexisting disease that results in an increase in absorbed
dose, biologically effective dose, or target tissue response. If biomarkers of susceptibility exist, they
are discussed in Section 2.7, “Populations That Are Unusually Susceptible.”
2.5.1 Biomarkers Used to Identify or Quantify Exposure to Stoddard Solvent
No biomarkers are available to specifically identify or quantify exposure to Stoddard solvent.
However, hydrocarbon levels in the blood can be used to document exposure to petroleum distillates in general.
Components of white spirits have been identified in human blood, fat, and alveolar air using gas chromatography-mass
spectrometry (Pedersen et al. 1984). It may be possible to identify Stoddard solvent in this way, comparing the
measured sample to the spectrometrical pattern of a known Stoddard solvent standard.
Minimal information is available on the half life of Stoddard solvent in the body. One study showed
that levels of aliphatic and aromatic components in alveolar air dropped substantially within
20 minutes of exposure (Astrand et al. 1975). However, measurable amounts remained in the blood
for at least 100 minutes post-exposure. In the second study, the rate of inhalation absorption of the
alkane components was fairly constant over the different exposure intervals (5 days, 6 hours/day) that
were measured. The mean blood concentration of white spirits was 2 mg/L on day 1 and 2.54 mg/L
on day 5, showing accumulation of white spirits in the blood (Pedersen et al. 1984, 1987).
Following repeated exposure (600 mg/m3) to white spirits (6 hours/day for 5 days), only 23% of the
concentration in body fat was removed over a 60-hour period of non-exposure (Pedersen et al. 1984).
Studies of certain components of Stoddard solvent indicate that their metabolites may be useful
indications of exposure, provided the interaction of the components in the mixture does not interfere
with their metabolism. A correlation between exposure to 1,2,4-trimethylbenzene (a component of
white spirits) and a urinary concentration of 3,4-dimethylhippuric acid (a metabolite of 1,2,4-
trimethylbenzene) was reported in workers exposed at the TLV-TWA (25 ppm) (Fukaya et al. 1994).
Another study of humans exposed to white spirits found that levels of dimethylbenzoic acid, another
metabolite of trimethylbenzene, in the urine correlated to earlier exposure during the workday (Pfaffli
et al. 1985). A study of humans exposed to up to 2,500 mg/m3 of Stoddard solvent found that
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aliphatic and aromatic components remained in the blood roughly 1.5 hours after the termination of
exposure (Astrand 1975). Fischer-344 rats dosed by gavage with 800 mg/kg of t-butylcyclohexane, a
component of white spirits, were found to have seven metabolites in their urine (Henningsen et al.
1987). The primary metabolite was trans-4-t-butylcyclohexanol.
2.5.2 Biomarkers Used to Characterize Effects Caused by Stoddard Solvent
Since the effects of Stoddard solvent are not unique to this chemical, no specific biomarkers are
available to characterize the effects caused by Stoddard solvent. Headaches, fatigue, incoordination,
and skin irritation are general effects which may be encountered following exposure to Stoddard
solvent. It is expected that these effects would occur for short periods of time. Other effects, such as
bronchitis and pulmonary congestion or emphysema may occur over a longer period of time; their
onset is relatively fast and some of the effects are reversible when the person is removed from the
exposure situation. However, the durations of the health effects are not well documented in the data.
If Stoddard solvent is aspirated into the lungs following oral exposure, it is possible that pulmonary
damage may occur, as it does with other petroleum distillates, such as kerosene (Haddad and
Winchester 1990). Symptoms such as coughing, choking, or gagging might appear, along with clinical
signs such as fever. Chemical pneumonitis may be revealed by chest x-rays. The abnormal chest
x-rays may be present 30 minutes after aspiration. Radiological changes are usually detected up to
several days after exposure, but can remain evident for several weeks or months (Haddad and
Winchester 1990). However, there are numerous chemicals that may induce these effects. Therefore,
it would be difficult to identify Stoddard solvent as the cause based on these symptoms in cases of
unidentified chemical exposure.
2.6 INTERACTIONS WITH OTHER CHEMICALS
Although workers are often exposed to a variety of solvents with Stoddard solvent, there are no
available studies-specifically characterizing the interactions of Stoddard solvent with other chemicals.
Since Stoddard solvent may have adverse effects on the nervous system, it may compound the effects
of other chemicals that cause central nervous system depression, such as alcohol, barbiturates,
benzodiazapines, or medical anesthetics. Guinea pigs with a diet high in vitamin C survived a high
exposure to Stoddard solvent vapors better than those with a diet low in vitamin C (Jenkins et al
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1971); however, it is not known how vitamin C levels might affect humans exposed to Stoddard
solvent.
2.7 POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE
A susceptible population will exhibit a different or enhanced response to Stoddard solvent than will
most persons exposed to the same level of Stoddard solvent in the environment. Reasons include
genetic make-up, developmental stage, health and nutritional status, and chemical exposure history.
These parameters result in decreased function of the detoxification and excretory processes (mainly
hepatic and renal) or the pre-existing compromised function of target organs. For these reasons we
expect the elderly with declining organ function and the youngest of the population with immature and
developing organs will generally be more vulnerable to toxic substances than healthy adults.
Populations who are at greater risk due to their unusually high exposure are discussed in Section 5.6,
“Populations With Potentially High Exposure.”
There is no information on populations that may be unusually susceptible to Stoddard solvent.
Individuals with pre-existing neurological conditions are likely to be a population of concern due to
the neurological effects noted after exposure to Stoddard solvent and white spirits. Stoddard solvent
has been shown to be irritating to the eyes and possibly the respiratory system. Therefore, persons
susceptible to eye or respiratory diseases might be unusually susceptible to the effects of Stoddard
solvent. Because there is uncertainty about adverse renal effects occurring in humans due to exposure
to Stoddard solvent, persons with kidney diseases also may be unusually susceptible to the effects of
Stoddard solvent exposure. Glomerulonephritis is known to have a genetic component (Bombassei and Kaplan 1992;
Rambausek et al. 1993).
Additionally, persons with higher percentages of body fat might be more likely to store these solvents,
since the solvent lipophilicity is a pharmacokinetic characteristic. In general, there would be a
potentially greater storage in women, due to their increased relative volume of body fat, than in men
(Sato and Nakajima 1987).
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2.8 METHODS FOR REDUCING TOXIC EFFECTS
This section will describe clinical practice and research concerning methods for reducing toxic effects
of exposure to Stoddard solvent. However, because some of the treatments discussed may be
experimental and unproven, this section should not be used as a guide for treatment of exposures to
Stoddard solvent. When specific exposures have occurred, poison control centers and medical
toxicologists should be consulted for medical advice.
2.8.1 Reducing Peak Absorption Following Exposure
Little information is available on specific methods for reducing absorption after exposure to Stoddard
solvent itself. However, it is a petroleum distillate, and information on related products is available.
Since the absorption from the gastrointestinal tract is likely to be poor, the use of activated charcoal or
cathartics would probably not be useful for alkane and cycloalkane components (Klein and Simon
1986; Litovitz and Greene 1988). Further data are required to determine if either activated charcoal or
cathartics will remove the aromatic components of Stoddard solvent. Gastric emptying by either
lavage or emesis is a controversial treatment since there is the danger of pulmonary aspiration and
subsequent pneumonitis (Ellenhorn and Barceloux 1988; Haddad and Winchester 1990; Klein and
Simon 1986; Litovitz and Greene 1988). Although the inhalation route is the most probable route of
exposure, the only known method to reduce exposure is to remove the person from the contaminated
area (Stutz and Janusz 1988). Excessive inhalation of solvents often leads to central nervous system
depression and may require assisted ventilation. The acute effects of central nervous system
depression, such as seizures, are often treated with naloxone and glucose. If pulmonary distress is
present, it has been suggested that positive end expiratory pressure be used therapeutically (Haddad
and Winchester 1990; Klein and Simon 1986). Washing with soapy water is suggested following
dermal contact, and ocular washing is suggested following eye exposure.
2.8.2 Reducing Body Burden
There are no effective methods to enhance elimination of Stoddard solvent and no known antidotes.
Since inhalation is the most probable route of exposure, removing the person from the contaminated
area may help to reduce the body burden (Stutz and Janusz 1988). Stoddard solvent can be stored in
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adipose tissue; thus, the effects may continue for a few days after exposure has occurred as Stoddard
solvent is released from storage.
2.8.3 Interfering with the Mechanism of Action for Toxic Effects
The mechanism of action of Stoddard solvent on the target organ (i.e., the brain) is not known. Also,
no information was located that provided therapeutic measures designed to interfere with a possible
mechanism of action for Stoddard solvent. In the kidney, the mechanism of action of Stoddard solvent
appears to be specific to male rats, which synthesize α2µ-globulin, a protein not found in humans. This
protein is believed to interact with Stoddard solvent and to cause pathological changes in the P2
proximal tubule epithelium and other renal effects. Because the α2µ-globulin nephropathy is not
believed to affect humans, interfering with this particular mechanism of action would not be relevant.
2.9 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with
the Administrator of EPA and agencies and programs of the Public Health Service) to assess whether
adequate information on the health effects of Stoddard solvent is available. Where adequate
information is not available, ATSDR, in conjunction with the National Toxicology Program (NTP), is
required to assure the initiation of a program of research designed to determine the health effects (and
techniques for developing methods to determine such health effects) of Stoddard solvent.
The following categories of possible data needs have been identified by a joint team of scientists from
ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that, if met,
would reduce or eliminate the uncertainties of human health assessment. This definition should not be
interpreted to mean that all data needs discussed in this section must be filled. In the future, the




2.9.1 Existing Information on Health Effects of Stoddard Solvent
The existing data on health effects of inhalation, oral, and dermal exposure of humans and animals to
Stoddard solvent are summarized in Figure 2-2. The purpose of this figure is to illustrate the existing
information concerning the health effects of Stoddard solvent. Each dot in the figure indicates that
one or more studies provide information associated with that particular effect. The dot does not imply
anything about the quality of the study or studies. Gaps in this figure should not be interpreted as
“data needs” information (i.e., data gaps that must necessarily be filled).
2.9.2 Identification of Data Needs
Acute-Duration Exposure. The available data indicate that following a 6-hour exposure, there is a
lack of systemic or neurological effects in humans exposed to low levels (610 mg/m3) via the
inhalation route (Pedersen and Cohr 1984a, 1984b). Humans and animals exposed to airborne,
completely vaporized Stoddard solvent at higher levels for acute periods had eye irritation (Carpenter
et al. 1975a, 1975b; Hastings et al. 1984) and neurological disturbances (Gamberale et al. 1975). A
neurological NOAEL was observed in humans exposed by inhalation to a time-weighted average of
1,563 mg/m3 for 2 hours (Gamberale et al. 1975). Further information on levels that would be
expected to cause effects following acute, intermediate, or chronic exposure in the air would be useful.
No data on oral exposure were available for any duration in any species. Acute dermal exposure
resulted in skin irritation in humans (Nethercott et al. 1980) and animals (Anderson et al. 1986). The
data were not sufficient to derive an MRL for the oral or dermal routes of exposure. Specifically, data
are needed to establish a NOAEL for functional neurological tests in humans after inhalation exposure
for a duration longer than 2 hours.
More information is needed to follow up on the potential musculoskeletal toxicity, as indicated by
increased creatinine kinase levels, following acute human exposure to Stoddard solvent (Pedersen and
Cohr 1984b). Data from all routes of exposure, for all end points, would be useful in determining
levels that may be harmful to humans at hazardous waste sites. Furthermore, acute neurological
studies of longer durations would be useful since the studies located had exposures of 3 days or less.
In particular, studies are needed on upper respiratory/nasal effects observed that have included




and trachea (Riley et al. 1984), and nasal irritation (Carpenter 1975a, 1975b; Larsen and Schumes
1974). Renal studies would be useful in elucidating whether the enzyme changes suggesting distal
tubular damage, noted after 10 days of exposure in rats, can be verified (Viau et al. 1986). This is the
only study suggesting injury to the kidney in a location other than the proximal tubule; however,
further studies are needed before distal tubule damage can be ruled out. It would also be useful to
have further data from muscular function tests that relate to increased serum creatinine kinase levels
(Pedersen and Cohr 1984b).
Intermediate-Duration Exposure. No studies are available regarding intermediate-duration human
exposure by any route. Intermediate-duration rat studies reveal damage to the male rat kidney
(Carpenter et al. 1975a, 1975b; Phillips 1983; Rector et al. 1966; Viau et al. 1984). It has not been
ascertained whether the hyaline droplets observed in the rat renal studies were composed of
α2µ-globulin instead of other resorbed proteins. This needs to be determined to ensure that Stoddard
solvent is indeed acting by inducing male rat-specific α-globulin nephropathy and not by another
mechanism which might have more relevance to humans. It would be helpful to know whether human
lipocalin proteins bind Stoddard solvent components or metabolites and if lipocalin renal catabolism is
affected. Since the renal damage may be exclusive to male rats, no human MRLs have been derived
from data regarding this end point. Other end points were studied in two major 13-week
(5 days/week) experiments and a 6-week experiment that used several species (Carpenter et al. 1975a,
1975b; Rector et al. 1966). No adverse systemic effects were found at exposures of up to
1,900 mg/m3, but there were unexplained deaths in guinea pigs at 363 mg/m3, and, because study
interpretation was compromised, no MRL could be derived from this end point. No data are available
from animals for the oral or dermal routes. Further information for all routes would be necessary to
develop intermediate-duration MRLs.
Chronic-Duration Exposure and Cancer. The incidence of death was investigated in a single
retrospective cohort study among 14,457 workers at an aircraft maintenance facility following
exposure to very low levels of Stoddard solvent as well as numerous other chemicals for at least l
year (Spirtas et al. 1991). An exposure index was developed by evaluating patterns of use that
indicated comparative differences in exposure to various chemicals based on occupation. However,
exposures could not be quantitated from these methods. The study did not show a statistically
significant increase in mortality. Adverse neurological effects have been reported in humans




noted (Tuohimaa and Wichmann 1981). However, the study was limited due to the small population
sample size, questionable accuracy of the exposure assessment, exposure to mixed solvents, and
variability of sperm parameters” Observations of systemic effects have been made in humans
following chronic exposure (Beving et al. 1991; Flodin et al. 1984; Hane et al. 1977; van der Laan
1980). No studies are available regarding chronic-duration animal exposures by the inhalation or oral
routes. Since none of the human studies provide quantitative data suitable for the derivation of an
MRL, further studies for all routes and end points would be useful in determining possible effects in
humans living near hazardous waste sites, particularly more studies addressing glomerulonephritis and
atrophy of the brain cortex, including development of animal models. To fully exclude glomerulonephritis as an effect
of Stoddard solvent exposure, epidemiological (case-control, cross-sectional, or prospective cohort) studies examining
renal outcomes in exposed workers would be particularly useful.
The only available study on cancer in humans is limited by its lack of statistical power (Siemiatycki et
al. 1987). The only chronic animal study is a briefly reported dermal study on possible carcinogenic
effects in mice that was limited by the use of a mixture containing Stoddard solvent (90% Stoddard
solvent, 7% calcium petroleum sulfonate, and 3% ethylene glycol monobutyl ether) (EPA 1984c). A
follow-up to this study, using Stoddard solvent alone, would be useful. Concerns have been raised
about the genotoxicity of some individual components of Stoddard solvent. Treatment of V79 Chinese
hamster cells by n-decane alone did not cause mutagenesis, but in combination with methylazoxylmethanol (MAM), it
appeared to promote mutagenesis (Lankas et al. 1978). Several studies have shown that some n-alkane components of
Stoddard solvent are promoters of carcinogenicity (Site 1966; Saffiotti and Shubik 1965; Van Duuren and
Goldschmidt 1976). Other studies raise questions about whether some of the n-alkane components may also be co-
carcinogens (Bingham and Falk 1969; Horten et al. 1957, 1966, 1976; Van Duuren and Goldschmidt 1976).
Carcinogenicity studies utilizing Stoddard solvent mixtures containing these components would be useful.
Genotoxicity. Most of the available in vitro and in viva studies indicate that neither Stoddard
solvent nor white spirits pose a genotoxic threat (API 1978a, Conaway et al. 1984; Gochet et al.
1984). However, based on these few studies, it would be presumptuous to definitively state that
Stoddard solvent/white spirits is not genotoxic to humans, especially since some individual components of Stoddard
solvent are promoters of carcinogenicity. Extensive in vitro investigations, especially Ames testing, are probably not




Reproductive Toxicity. The only available human study shows no adverse effects on the sperm of
men exposed for a chronic period (Tuohimaa and Wichmann 1981). Further intermediate screening
tests assessing in vitro sperm fertilization ability would be useful in determining that this substance
poses no reproductive risk. More information on the effects of inhalation exposure on FSH levels is
needed In order to confirm that the decreases in FSH noted in men exposed for an acute period are
exposure related and not a result of individual variations or not just extremely transient (Pedersen and
Cohr 1984b). Multigenerational animal studies could be considered.
Developmental Toxicity. No human data are available regarding developmental toxicity. The only
available animal study reported no skeletal or visceral abnormalities in the offspring of rats following
inhalation exposure of the dams (API 1977). This study is not sufficient to determine that humans
have no risk of developmental effects Further animal studies using all routes of exposure would be
useful.
Immunotoxicity. The only study available regarding immunological effects showed no changes in
immunoglobulins in humans exposed to the alkane components for an acute period via the inhalation
route (Pedersen and Cohr 1984b). No intermediate- or chronic-duration studies are available in
humans, and no studies are available for animals for any route or duration. However, immunotoxicity
may have occurred in an individual who developed glomerulonephritis from chronic dermal and/or
inhalation exposure (Daniell et al. 1988). Although this is a renal effect, it may have been induced by
an immunotoxic reaction to Stoddard solvent as evidenced by the finding of antibodies to the
glomerular basement membrane. Therefore, data are needed to determine whether Stoddard solvent
affects the immune system to induce renal toxicity. Further studies for all duration categories in both
humans and animals would be useful to determine whether this substance poses an immunological
threat via the inhalation, oral, or dermal routes. For example, studies could be conducted to determine
whether animals or humans exposed to Stoddard solvent are more susceptible to infection or whether
Stoddard solvent induces a dermal sensitivity reaction; macrophage, T and B lymphocyte, and natural
killer cell function could be tested in animals and individuals exposed to Stoddard solvent.
Neurotoxicity. Acute-duration human studies via the inhalation route (Carpenter et al. 1975a, P975b; Gamberale et al.
1975; Hastings et al. 1984; Larsen and Schmunes 1974; Pedersen and Cohr 1984a, 1984b) as well as chronic-duration
human studies via the inhalation and dermal routes (Arlien-Soborg et al. 1979; Daniel1 et al. 1988; Flodin et al. 1984;
Gregersen et al. 1984; Hane et al. 1977; Mergler et
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al. 1988; Mikkelsen et al. 1988; Olson 1982) are available. The chronic studies reported findings after
mixed solvent exposures. A NOAEL was found in humans exposed to a time weighted average of
1,563 mg/m3 for 2 hours (Gamberale et al. 1975). No oral studies are available for humans. For
animals, neurological effects have been studied following acute-duration inhalation exposure only
(Carpenter et al. 1975a, 1975b). No animal data are available on neurological effects following
intermediate- or chronic-duration inhalation exposure. No animal data are available regarding oral or
dermal exposure. Since the nervous system appears to be a target organ in humans, further human and
animal studies of exposure via all three routes would be useful in determining safe levels for
inhalation, oral, or dermal exposure at hazardous waste sites.
Epidemiological and Human Dosimetry Studies. Although there have been studies of persons
exposed to Stoddard solvent or white spirits at the workplace, none have recorded exposure levels. A
prospective occupational study that provides exposure levels would be useful in determining standards
that would protect persons exposed at hazardous waste sites
Biomarkers of Exposure and Effect. There are no studies available to determine specific
biomarkers of exposure or effect. Components of Stoddard solvent can be measured in the blood, fat,
and breath. Fat appears to be the best compartment to sample for chronic exposure, since Stoddard
solvent is extremely lipid soluble (Pedersen et al. 1984, 1987). However, these chemicals can be
found in many types of petroleum distillates and are not specific to Stoddard solvent. Additional
research that identifies Stoddard solvent exposure using currently available breathalizer techniques with mass
spectroscopy would also be useful.
Similarly, the biomarkers of effects from Stoddard solvent are very general (headaches, fatigue,
incoordination, skin irritation, bronchitis, coughing, and abnormal chest x-rays) and cannot be used to
document exposure. Any further information on biomarkers of exposure or effect would be useful.
Absorption, Distribution, Metabolism, and Excretion. There are very few humanstudies
(Pedersen et al. 1984, 1987; Astrand et al. 1975), and no animal studies, regarding toxicokinetics,
although Astrand et al (1975) did study the absorption of Stoddard solvent in humans. Further studies
in both animals and humans would be very useful in determining possible adverse health effects at
hazardous waste sites. In particular, information on the rate and extent of absorption and mode of
excretion would be useful in predicting health effects as well as in determining possible mitigation
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methods. For example, establishing methods for determining gastrointestinal absorption and molecular
weight cutoffs for lipophilic absorption would be useful. Also, better pharmacokinetic data on the
three main classes of Stoddard solvent components (i.e., alkanes, cycloalkanes, and aromatics) would
help predict the toxic properties of this chemical. Identification of the metabolic products of Stoddard
solvent components is also a data need.
Comparative Toxicokinetics. Since there is sparse data on animal toxicokinetics, there is no
information at all on comparative toxicokinetics. Studies of absorption, distribution, metabolism, or
excretion would be appropriate in multiple animal species for interspecies comparisons. Comparisons
between the pharmacokinetic properties of petroleum distillates of varying chain lengths and aromatics versus other
hydrocarbon classes would also be useful.
Methods for Reducing Toxic Effects. Very little information is available for Stoddard solvent
itself, or for petroleum distillates as a class. There are no known antidotes for these substances, and i
is unlikely that research to find a specific antidote to Stoddard solvent poisoning would be effective.
Since there are no human or animal data on oral exposure to Stoddard solvent, no treatment methods
have been attempted. Further studies regarding the effectiveness of gastric lavage and the
administration of activated charcoal would be useful. Additional studies regarding which Stoddard
solvent components are absorbed in the gastrointestinal tract and whether or not activated charcoal
absorbs them would also be beneficial. Further research on alternative treatment methods, such as
using negative pulmonary pressure, would be appropriate.
2.9.3 On-going Studies
There are no known on-going studies on Stoddard solvent.
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3.1 CHEMICAL IDENTITY
Information regarding the chemical identity of Stoddard solvent is located in Table 3- 1.
3.2 PHYSICAL AND CHEMICAL PROPERTIES
Information regarding the physical and chemical properties of Stoddard solvent is located in Table 3-2.
Stoddard solvent is a petroleum distillate mixture of C7-C12 hydrocarbons. The mixture consists of
three major groups of components: linear and branched alkanes, also known as paraffins (30-50% of
the total mixture); cycloalkanes, also called cycloparaffins or naphthenes (not to be confused with
naphthalenes which are bicyclic aromatics) (30-40%), and aromatic hydrocarbons (l0-20%) (Air Force
1989b; McDermott 1975). Stoddard solvent is a refinery blend of differently treated oil fractions. Its
composition varies somewhat, depending on the refinery and the time of production. Table 3-3 lists
some of the major components of several Stoddard solvent formulations. Petroleum distillates are
often distinguished by boiling or distilling temperatures. Stoddard solvent has a boiling range of
150-200°C (Scott et al. 1959). The 140 flash Stoddard solvent is composed of C5-C12 hydrocarbons
and has a boiling range of 185-207°C (Air Force 1989b). White spirits is a term somewhat
synonymous with Stoddard solvent since it has a hydrocarbon range between C7 and C11. Six types of
white spirits have been identified based on origin. Each type consists of the same components, but the
percentages vary (Scheffers et al. 1985). Possible contaminants of Stoddard solvent include lead
(<1 ppm) and sulfur (3.5 ppm) (Suntech 1978).
There are a number of related chemical mixtures with components that are different from those of
Stoddard solvent. For instance, high-flash aromatic naphtha is a generic term for petroleum distillates
primarily consisting of C9 aromatics (70-80%) with C8 or C10 aromatics comprising the rest. Stoddard
solvent, in contrast, is only l0-20% aromatic (Clark et al. 1989b; Schreiner et al. 1989). Naphtha is
also a general term for petroleum distillates containing predominantly C5-C13 aliphatic hydrocarbons
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Benzine and mineral spirits (other associated mixtures) are similar to but not exactly the same as
Stoddard solvent. Benzine consists of C5-C9 hydrocarbons (Takeuchi et al. 1975) and boils, on
average, at between 154°C and 204°C (Navarte et al. 1989). Benzine and Stoddard solvent distill at
about the same temperature range, but their hydrocarbon compositions differ. Mineral spirits have a
distillation range of 136-277°C. The distillation range of Stoddard solvent falls within that of mineral
spirits (Mehlman and Smart 1982). Therefore, Stoddard solvent may be considered a subset of
mineral spirits, but mineral spirits as a whole are not described in this profile.
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4.1 PRODUCTION
Stoddard solvent is a chemical mixture containing hydrocarbons that range from C7 to C12 with the
majority of hydrocarbons in the C9-C11 range (Air Force 1989b; Rothman and Emmett 1988). The
hydrocarbons composing Stoddard solvent are 30-50% alkanes, 30-40% cycloalkanes, and l0-20%
aromatics (Air Force 1989b; McDermott 1975). Stoddard solvent is considered to be a form of
mineral spirits, white spirits, and naphtha; however, not all forms of mineral spirits, white spirits, or
naphtha are considered to be Stoddard solvent. Stoddard solvent is produced from straight-run
distillate of paraffinic or mixed base crude oil (Air Force 1989b; Rothman and Emmett 1988) and
must meet the specifications of the American Society for Testing and Materials designation for Type I
mineral spirits (Stoddard solvent) (ASTM 1988, 1992). In 1990, the production volume of Stoddard
solvent was 38,325,834 pounds, down from a volume of 74,851,222 pounds in 1986 (EPA 1992). The
U.S. companies that produce and/or distribute Stoddard solvent are Ashland Chemical, Inc.; R.E.
Carroll, Inc.; Chemcentral Corporation; Coyne Chemicals; Holtrachem, Inc.; MacArthur Petroleum and Solvent
Company, Inc.; TEXACO Chemical Co.; Unocal Chemicals; and Van Waters and Rogers, Inc. (Hunter et al. 1992;
Van and Deyrup 1992). Since Stoddard solvent is not required to be reported under SARA Section 313, there are no
data for this compound in the 1990 Toxics Release Inventory (TRI90 1992).
4.2 IMPORT/EXPORT
No information regarding the import or export of Stoddard solvent was located.
4.3 USE
Stoddard solvent is a multipurpose petroleum solvent (McDermott 1975). Industrial uses include paint
vehicles; thinning agent for paints, coatings, and waxes; printing inks; adhesives; and as a solvent in
liquid photocopier toners (Air Force 1989b; McDermott 1975). Stoddard solvent is commonly used at
air fields as a degreaser for precision engine parts in machine shops and in automotive repair
applications.
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4.4 DISPOSAL
Disposal of Stoddard solvent should be in accordance with government regulations for the disposal of
petroleum distillates (IRPTC 1985; MSDS-CCOHS I992). Stoddard solvent has been designated as a
hazardous waste by the Department of Transportation and, as such, should not be poured down
domestic sewage drains. Carefully controlled incineration is one recommendation for proper disposal.
Authorized disposal services should perform or oversee the relegation procedure (MSDS-CCOHS
1992). Recycling, of course, is an alternative to disposal, and since recycling is a suggested waste
management technique for petroleum distillates, it should apply to Stoddard solvent as well (IRPTC
1985).
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5.1 OVERVIEW
Stoddard solvent is a mixture of hydrocarbons derived by refining crude oil; its environmental fate is
dependent on the physical and chemical properties of the individual components. The hydrocarbon
chain length ranges from C7 to C12, although a form of Stoddard solvent called 140 flash contains C5
and C6 hydrocarbons as well. These hydrocarbons consist primarily of linear and branched alkanes
(also called paraffins) (30-50% of the total mixture), cycloalkanes (30-40%), and aromatics (l0-20%).
Stoddard solvent may be released to the environment during its use as a solvent in dry cleaning plants
or as an industrial degreasing agent. It may also enter water or soil as a result of spills during use or
transportation or from leaking shipping and storage containers such as 55-gallon drums. The lower
molecular weight alkanes and aromatics may volatilize and undergo photodegradation in the
atmosphere, while higher-molecular-weight alkanes and cycloalkanes tend to be sorbed to organic
matter in soil or water. Lower-molecular-weight alkanes may also be sorbed to organic matter if
volatilization is not rapid. The higher-molecular-weight aromatic components may dissolve in surface
waters, or they may desorb from soil particles and leach into the groundwater. Biodegradation is
expected to be the primary fate process for Stoddard solvent in soil and water, except that fraction
which has volatilized. The rate of biodegradation is dependent on the ambient temperature, the
presence of a sufficient number of microorganisms capable of metabolizing these hydrocarbons, and
the concentration of Stoddard solvent in or on the soil or water. If biodegradation occurs under anoxic
conditions, then the availability of Fe(III) may influence the biodegradation of aromatics (Lovley et al.1994).
Exposure of the general population to Stoddard solvent may result primarily from inhalation or dermal
contact when it is used for such commercial purposes as dry cleaning, degreasing in machine shops,
and in paints. Individuals living in areas where Stoddard solvent may have contaminated the soil may
be exposed if it has entered their homes through volatilization from the soil, has been transported in
flowing groundwater, or if they play or otherwise come in direct contact with contaminated soil.
Inhalation of the volatile components of Stoddard solvent is likely to be the main route of occupational exposure for
individuals employed in dry cleaning plants where it is used as a cleaning solvent,
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machine shops where it is used as a degreasing agent, and other industries where Stoddard solvent is
used for a variety of purposes. Dermal exposure is also possible if machine parts that have been
degreased in Stoddard solvent are not dry when handled or protective clothing is not worn.
Stoddard solvent has been identified in at least 7 of the 1,397 hazardous waste sites on the EPA
National Priorities List (NPL) (HAZDAT 1994). The frequency of these sites within the United States
can be seen in Figure 5-1.
5.2 RELEASES TO THE ENVIRONMENT
Stoddard solvent may be released to the atmosphere in the exhaust emissions of dry cleaning plants.
Emissions from one plant were determined to be 2,100 ppm (measured as propane) (EPA 1980).
Fugitive emissions from other industrial or domestic uses (such as incompletely sealed or punctured
barrels) may contribute to levels of Stoddard solvent in the environment, including contributions to
general levels of volatile organic carbon. In addition, surface water contamination may occur as a
result of direct spills of Stoddard solvent onto surface waters, runoff from spills to soil with
subsequent transmission to nearby water sources, or from improper disposal, such as pouring Stoddard
solvent down drains. Accidental spills of Stoddard solvent to various media are reported to the
Emergency Response Notification System (ERNS) maintained by EPA. Total spill data for Stoddard
solvent are:
Year Media Quantity spilled in pounds Kilograms
1991 Land 2,020    918.2
Water 8,580 3,900
1992 Land      33      15
Water        0        0
No spills were reported to air, groundwater, at facilities, or for other types of releases. In addition, no
spills of Stoddard solvent were reported in 1993 (ERNS 1993).
Releases of Stoddard solvent are not required to be reported under SARA Section 313; consequently,
there are no data for this compound in the 1990 Toxics Release Inventory (TRI90 1992). There are
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seven NPL sites where Stoddard solvent is present in waste materials or containers. It is unknown
whether there have been releases to the environment from these sites (HAZDAT 1994).
5.2.1 Air
No information was located on releases of Stoddard solvent to the atmosphere.
5.2.2 Water
Stoddard solvent may be released to surface waters as a result of spills, in runoff from industrial
facilities where it is used as a solvent, or from the intentional disposal of excess solvent down drains.
Stoddard solvent is not listed in the Contract Laboratory Program Statistical Database (CLPSD) of
chemicals detected in groundwater and surface water samples taken only at NPL sites. Stoddard
solvent itself, as a hydrocarbon mixture, is not included as a target chemical at NPL sites, but some
components of the Stoddard solvent mixture such as alkanes, substituted benzenes, and naphthalenes
have been detected in groundwater and surface water samples (CLPSD 1989). However, the presence
of these compounds does not necessarily imply contamination by Stoddard solvent.
5.2.3 Soil
Stoddard solvent is not listed in the CLPSD of chemicals detected in soil samples taken only at NPL
sites; however, while Stoddard solvent, as a hydrocarbon mixture, is not included as a target chemical,
some components such as alkanes, substituted benzenes, and naphthalenes have been detected in soil
samples (CLPSD 1989). However, the presence of these compounds does not necessarily imply
contamination by Stoddard solvent.
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5.3 ENVIRONMENTAL FATE
5.3.1 Transport and Partitioning
The transport and partitioning of Stoddard solvent is dependent on the environmental fate of its
hydrocarbon components. Based on Mackay’s equilibrium partitioning model using low concentrations (below
maximum aqueous solubility) of Stoddard solvent, sorption to organic matter in soil or water is a major partitioning
process for all hydrocarbon classes (alkanes, cycloalkanes, and aromatics) with partitioning to the soil-vapor phase
being relatively unimportant. At low concentrations, the aromatic constituents of Stoddard solvent, particularly the
alkyl benzenes, are more water soluble than alkanes and cycloalkanes and may dissolve in infiltrating water with a
minimum of volatilization. As such, the model indicates, they may be transported through soil into the underlying
groundwater, although sorption to soil organic matter wilB retard this leaching process. For saturated deep soils that
contain no oxygen and little organic matter, the model predicts that some (20%) aromatic hydrocarbons will not
undergo biodegradation, but will be dissolved in the soil-water phase, and subsequently will be transported to
underlying groundwater (Air Force 1989b).
If a release of Stoddard solvent exceeds the sorptive capacity of the soil, the equilibrium partitioning
model is no longer applicable. Large quantities of Stoddard solvent may move through the soil with
gravity as bulk fluid and enter the groundwater. At the soil/groundwater interface, the soluble
components can dissolve in the water, while insoluble components with specific gravities of less than
1 will float on top of the water table and move horizontally along the soil/water interface (Air Force
1989a). In addition, horizontal movement of Stoddard solvent through the soil, particularly through
cracks and fissures in the soil material, is possible if the concentration is large enough to exceed the
sorptive capacity of the soil or if the release has occurred below the surface of the soil (for example
from a leaking underground storage tank).
Alkanes are likely to be sorbed to organic matter in the soil and are, therefore, unlikely to be dissolved
in water moving through soil. However, some of these compounds may volatilize more quickly than
they will bind to organic matter. Most aliphatic hydrocarbons have low water solubilities, but those
with higher water solubilities are likely to be dissolved in water and may be transported through soil
more rapidly, although the extent may be reduced by sorption to organic matter or volatilization (Air
Force 1989a).
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Laboratory studies have shown that mineral spirits are sorbed by fresh snow with a mean sorption ratio
of 1.5 g mineral spirits/g snow. This would indicate that if a spill occurred on a snow-covered site, not
only would sorption to soil be decreased if the ground were frozen, but drainage from the site
would be decreased due to snow sorption (Marte% and Nadeau 1994). When the snow melted, the
solvent would be expected to be transported in the same way as the melted snow.
No information was found on the bioaccumulation potential of Stoddard solvent in either aquatic or
terrestrial ecosystems. However, the potential for bioaccumulation of Stoddard solvent in either
ecosystem is dependent on the bioaccumulation potential of the individual hydrocarbon components.
In general, lower molecular weight alkanes do not tend to bioaccumulate, aromatics may have a
moderate tendency to bioaccumulate, and the higher molecular weight alkanes, such as cycloalkanes,
tend to bioaccumulate (Air Force 1989a). However, these bioaccumulation tendencies may not be true
for all compounds within a class. Water-soluble aliphatics and aromatics may be expected to have low
bioconcentration factors based on their octanol-water partition coefficients (Menzer 1991). Although
no information is available on the bioconcentration of Stoddard solvent directly, aquatic organisms
have been found to bioconcentrate some of the hydrocarbons found in fuel oils, many of which are
also found in Stoddard solvent. Mussels exposed to fuel oil no. 2 were found to have significantly
increased concentrations of alkanes, cycloalkanes, and aromatics in their tissue on the first day of
exposure although by day 5 after removal from exposure, the n-alkanes were barely detectable and by
day 21, concentrations of a mixture of alkanes and cycloalkanes had decreased to 30% of the day 1
concentrations. Aromatic hydrocarbons decreased more slowly, to about 35% of the day 1 value at
21 days. The half-life of naphthalenes substituted at C-2 and C-3 were 0.9 and 1.5 days, respectively
(Farrington et al. 1982).
5.3.2 Transformation and Degradation
5.3.2.1 Air
Volatilization from soil and surface waters with subsequent rapid photooxidation in the atmosphere is
expected to be an important fate process for several constituents of Stoddard solvent based on its vapor pressure of 3.0
mmHg (at 20°C) and also, by analogy, based on the environmental fate of jet fuel 4 (JP-4), which contains similar
classes of hydrocarbons (Air Force 1989a). This is particularly true for the alkane constituents of Stoddard solvent with
low water solubilities. Low ambient temperatures
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tend to reduce the volatilization process. Other less volatile constituents of Stoddard solvent, such as
alkylbenzenes, are more likely to be affected by processes such as sorption or biodegradation.
5.3.2.2 Water
The C5-C9 hydrocarbon components of Stoddard solvent released to surface waters are primarily lost
by evaporation to the atmosphere. Higher-molecular-weight hydrocarbon components are most likely
to undergo biodegradation. Microorganisms capable of degrading these hydrocarbons have been found
in surface waters (Air Force 1989a). In aquatic environments, C10-C25 n-alkanes are degraded by
microorganisms, although biodegradation decreases as the hydrocarbons become more complex
(Edgerton 1987). Cometabolism by bacterial species may occur, but the transformation is generally
slow and its rate does not increase over time (Alexander 1994).
In aqueous environments, photooxidation of trisubstituted benzenes and naphthalenes may be quite
rapid, while alkanes, benzenes, and monosubstituted benzenes are relatively resistant to photooxidation (Air Force
1989a).
5.3.2.3 Soil
Stoddard solvent released to soil surfaces will undergo “weathering” over time that will result in
changes in the concentrations of the constituent hydrocarbons. A high percentage of low-molecularweight
hydrocarbons (such as C5-C9 alkanes and aromatics), if not sorbed, are likely to evaporate from soil rather than be
biodegraded (Air Force 1989a). Loss of higher-molecular-weight aliphatic and aromatic constituents of Stoddard
solvent will occur by both slow evaporation and by biodegradation.  Soil microorganisms may degrade certain
components of Stoddard solvent, with the rate of biodegradation being fast for low-molecular-weight aromatics.
Biodegradation is often slower for aliphatic hydrocarbons that are branched or cyclic or that contain 10 or more
carbons. The length of time required toachieve total degradation of Stoddard solvent may be substantial as
demonstrated by the degradation of another petroleum distillate, fuel oil no. 2, which was degraded by 86-90% after
1 year (Raymond et al. 1975, 1976). Sometimes, a small residual fraction may persist for many years.
Oxygen is used as an electron acceptor for microbial respiration and is a direct reactant in oxic
hydrocarbon oxidation (Lovley et al. 1994). In contaminated ground waters, oxygen may be added to
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enhance biodegradation. Anoxic conditions can occur after contamination of ground water. Water-
soluble aromatic hydrocarbons can be degraded under anoxic conditions, although the rate of
degradation will be slower than under aerobic conditions (Lovley et al. 1994).
Fe(II1) oxides can act as electron acceptors during the biodegradation of aromatic hydrocarbons in
shallow aquifers; however, these Fe(II1) oxides are frequently not bioavailable to microorganisms The
addition of organic ligands, which bind Fe(II1) and thus increase the bioavailability of Fe(III), has been
reported to increase the rate of biodegradation of aromatic hydrocarbons (including benzene) under
anoxic conditions (Lovley et al. 1994). Thus, the use of Fe(III) ligands might be valuable in the
bioremediation of hydrocarbon-contaminated, anoxic aquifers (Lovley et al. 1994). However, the
effects on the biodegradation of Stoddard solvent or its constituents, such as alkylbenzene, are not
known.
Stoddard solvent, applied to soil at a toxic concentration of 100 gallons per acre, reduced the number
of soil microorganisms by more than half (Persidsky and Wilde 1956), indicating that in areas
contaminated with high concentrations of Stoddard solvent, biodegradation rates may be decreased.
In order to determine the potential hazard to operators of landfill sites where solvents may be
disposed, the evaporation of white spirits (Stoddard solvent) from a simulated landfill site (using
pulverized domestic waste) was studied. Evaporation of Stoddard solvent from the landfill was
compared with its evaporation from a holding lagoon (using a liquid pool of the solvent). The volatile
components of Stoddard solvent initially evaporated rapidly from both sites, although the rate of
evaporation was much greater from the waste site. After 6 hours, the loss of solvent from the waste
was still twice that from the pool of liquid, suggesting that land application may pose a greater initial
hazard to site operators from fumes than would disposal by lagooning; however, other disposal
methods, such as incineration, are preferred (Jones and McGugan 1977).
5.4 LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT
5.4.1 Air
Stoddard solvent per se is not monitored in air; its volatile components, such as low-molecular-weight
alkanes and aromatics, are more likely to be detected as individual compounds in the air.
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Stoddard solvent, used in industrial paints for dump trucks, was present in the paint booth at
concentrations between 7.0 and 12.0 ppm (41.2-70.7 mg/m3) as determined by personal sampling
apparatus; however, this was considerably below the threshold limit value (time-weighted average) of
100 ppm for occupational safety (Bradley and Bodsworth 1983).
The use of hazardous wastes as fuel for industrial and commercial boilers may result in significant
population exposures to hazardous air emissions, particularly when compared with disposal in
incinerators regulated under the Resource Conservation and Recovery Act (RCRA) which must
achieve a removal efficiency of at least 99.99%. Using EPA’s population exposure and air dispersion
models, the potential population exposure was measured for five combustion scenarios (one
commercial incinerator and four boilers with varying capacities and destruction efficiencies) using
Stoddard solvent and the trimethylbenzene component of Stoddard solvent as potential industrial
waste streams.  Modeling results showed that the greatest exposure to emissions and the highest
emission concentrations were generated by a 15-million British thermal unit (Btu) boiler operating
at 97.0% destruction capacity. Under this scenario, the highest concentrations of Stoddard solvent and
trimethylbenzene to which people would be exposed were 103 µg /m3 and 15.4 µg/m3, respectively.
By comparison, a 75million Btu incinerator operating at 99.99% destruction and removal efficiency
would expose people to concentrations several orders of magnitude less (exact number unspecified)
(Coyle and Potenta 1983).
5.4.2 Water
No information was located on levels of the Stoddard solvent as a hydrocarbon mixture monitored in
surface or groundwater. Although some hydrocarbon components of Stoddard solvent have been
detected in water samples, it is not evident whether the source was a release of Stoddard solvent or
some other hydrocarbon mixture or compound.
5.4.3 Soil
No monitoring studies for Stoddard solvent as a hydrocarbon mixture in soil were located. Although
some hydrocarbon components of Stoddard solvent have been detected in soil samples, it is not
evident whether the source was a release of Stoddard solvent or some other hydrocarbon mixture or
compound.
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5.4.4 Other Environmental Media
No monitoring studies for Stoddard solvent in other environmental media were located.
5.5 GENERAL POPULATION AND OCCUPATlONAL EXPOSURE
According to the National Occupational Exposure Survey conducted from 1981 to 1983 by NIOSH,
1,922,235 employees (including 230,356 females) in 404 plants were potentially exposed to Stoddard
solvent in the workplace (NOES 1992). Most exposure was for persons employed as cleaners or
janitors. It is expected that workers who use Stoddard solvent as a degreasing agent or who work in
dry cleaning establishments or print shops where it is used as a solvent may have significant exposure
potential.
Transport of Stoddard solvent through soil and into groundwater may result in general population
exposure through the ingestion of contaminated drinking water or through inhalation or dermal
exposure during showering or bathing. Inhalation exposure may also result from the volatilization of
Stoddard solvent components from contaminated soil, including the diffusion of volatile components
through soil and into the basements of buildings (Air Force 1989b).
Use of Stoddard solvent in dry cleaning may result in the occupational exposure of workers in these
establishments, either through inhalation or dermal exposure (Air Force 1989b). The use of Stoddard
solvent (mineral spirits) in commercial paints may result in inhalation exposure, particularly if the
paint is applied with a sprayer (Fidler et al. 1987), as well as dermal exposures if protective clothing is
not worn (Air Force 1989b).
5.6 POPULATIONS WITH POTENTIALLY HIGH EXPOSURES
No studies were-located regarding populations with potentially high exposures; however, it is possible
that persons living or working near facilities that use Stoddard solvent may receive exposure to the
more volatile components.
Use of Stoddard solvent for painting and in printing inks increases the likelihood of exposure by
painters and others who work in areas where Stoddard solvent is used. In addition, people who use
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commercial products such as degreasers and paints which contain Stoddard solvent may also be
exposed by inhaling solvent vapors or by dermal contact with the product. Use of a respirator and
good ventilation can reduce exposure to the solvent vapors and protective clothing will help prevent
dermal contact.
5.7 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with
the Administrator of EPA and agencies and programs of the Public Health Service) to assess whether
adequate information on the health effects of Stoddard solvent is available. Where adequate
information is not available, ATSDR, in conjunction with NTP, is required to assure the initiation of a
program of research designed to determine the health effects (and techniques for developing methods
to determine such health effects) of Stoddard solvent.
The following categories of possible data needs have been identified by a joint team of scientists from
ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that, if met,
would reduce or eliminate the uncertainties of human health assessment. This definition should not be
interpreted to mean that all data needs discussed in this section must be filled. In the future, the
identified data needs will be evaluated and prioritized, and a substance-specific research agenda may
be proposed.
5.7.1 Identification of Data Needs
Physical and Chemical Properties. More information on the exact identity and properties of each of
the various formulations that are called Stoddard solvent would make it easier to distinguish
the toxicity and environmental effects caused by Stoddard solvent and to trace its fate based on levels
of distinguishing components, if any. Identification of components or ratios between different
components that may be used to distinguish Stoddard solvent from other hydrocarbon mixtures in
waste streams or other applications would be useful. See Table 3-3 for more information on possible
formulations of Stoddard solvent.
Production, Import/Export, Use, and Release and Disposal. Data on the potential for human exposure
are limited (Air Force 1989b; NOES 1992). Further information on current uses, production
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volumes, and releases of Stoddard solvent from industrial uses or as a result of its disposal would be
helpful in assessing the potential risk of exposure to this compound.
Environmental Fate. Stoddard solvent partitions to the various environmental compartments
according to the physical/chemical properties of its individual components. Major fate processes
include volatilization of low molecular weight alkanes and aromatics with photooxidation in the
atmosphere, sorption to soil and water organic matter for cycloalkanes and longer chain alkanes, and
dissolution of aromatic hydrocarbon constituents in water (Air Force 1989b). Biodegradation in soils
may be significant for the aliphatic and aromatic hydrocarbon components of Stoddard solvent that are
not primarily lost by evaporation (Air Force 1989a). The behavior of Stoddard solvent upon release to
the environment has not been well characterized. Limited information is available on the
environmental fate of the three hydrocarbon classes (linear and branched alkanes, cycloalkanes, and
aromatics) that comprise Stoddard solvent, although further study on the interactions of these classes,
particularly over time, would be useful in assessing the persistence and degradation of Stoddard
solvent in the environment. More data would be helpful on the use of Fe(III) ligands to increase
biodegradation of Stoddard solvent or its components under anoxic conditions in contaminated
aquifers. In addition, fate information regarding sorption to organic material in soil and water, derived
from the use of an equilibrium partitioning model, should be experimentally verified.
Bioavailability from Environmental Media. Since the factors characterizing the absorption of
Stoddard solvent are not known for humans or animals, the bioavailability is also unknown. There are
no data on whether Stoddard solvent released to soil or water will be absorbed by humans or animals
through contact with contaminated media. It is expected that the alkylbenzene components of
Stoddard solvent, being more water soluble than the alkanes and cycloalkanes, will be more readily
available for adsorption from contaminated waters. In addition, there are also no data to indicate
whether plants grown on contaminated soil or fish living in contaminated water are likely to absorb
Stoddard solvent or its constituents and thus enter the food chain. More data on possible rates and
extent of absorption through the inhalation, oral, and dermal routes would be useful in determining
bioavailability from environmental media.
Food Chain Bioaccumulation. No information was found on the bioaccumulation potential of
Stoddard solvent in either terrestrial or aquatic ecosystems; however, the individual components
making up the mixture may bioaccumulate depending on their individual properties. In general,
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polycyclic aromatic compounds may have the greatest tendency to bioaccumulate (Air Force 1989a).
Because these compounds account for such a small percentage of the mixture, bioaccumulation is not
expected to be a major exposure pathway for humans (Air Force 1989b). Research on the
biomagnification of Stoddard solvent would not be useful because it is not available to the food chain
as a mixture. It is possible that research on the biomagnification of some Stoddard solvent
components for which there is sparse data would be useful.
Exposure Levels in Environmental Media. There are very limited exposure data for air
concentrations of Stoddard solvent in areas where it is used as an industrial paint solvent (Bradley and
Bodsworth 1983). More data on levels in air resulting from other uses or storage or disposal would be
useful. Data on levels in contaminated surface water, groundwater, and soil are needed to assess the
potential risk from these likely sources of exposure.
Exposure Levels in Humans. Since characteristic ratios of the components of Stoddard solvent have not yet been
determined, monitoring information based on these ratios in the workplace or for the general population is not
available. Monitoring surveys that examine levels of Stoddard solvent in the workplace and for the populations living
or working in the vicinity of manufacturing or industrial use sites, or near disposal, dump, or leakage sites would be
useful in determining approximate levels of exposure for these populations, although there may be difficulties in
distinguishing exposure to Stoddard solvent versus other hydrocarbon mixtures, e.g., fuel oils or naphthas. Such
distinctions may be based on ratios of hydrocarbon components and determination of actual use of Stoddard solvent.
Exposure Registries. No exposure registries for Stoddard solvent were located. This substance is not
currently one of the compounds for which a subregistry has been established in the National
Exposure Registry. The substance will be considered in the future when chemical selection is made
for subregistries to be established. The information that is amassed in the National Exposure Registry
facilitates the epidemiological research needed to assess adverse health outcomes that may be related
to the exposure to this substance.
5.7.2 On-going Studies




The purpose of this chapter is to describe the analytical methods that are available for detecting and/or
measuring and monitoring Stoddard solvent in environmental media and in biological samples. The
intent is not to provide an exhaustive list of analytical methods that could be used to detect and
quantify Stoddard solvent. Rather, the intention is to identify well-established methods that are used
as the standard methods of analysis. Many of the analytical methods used to detect Stoddard solvent
in environmental samples are the methods approved by federal organizations such as EPA and the
National Institute for Occupational Safety and Health (NIOSH). Other methods presented in this
chapter are those that are approved by groups such as the Association of Official Analytical Chemists
(AOAC) and the American Public Health Association (APHA). Additionally, analytical methods are
included that refine previously used methods to obtain lower detection limits, and/or to improve
accuracy and precision.
6.1 BIOLOGICAL MATERIALS
Stoddard solvent is a mixture of aliphatic and aromatic hydrocarbons. The primary method used to
detect hydrocarbons in biological materials is gas chromatography (GC) either alone or in combination with
a mass spectrometer (MS). GC has been used to detect white spirits (99% C8-C12 aliphatics) in expiratory air
from the lungs, blood, and human adipose tissue. GUMS can also identify aromatics or cycloalkanes, if
present. See Table 6-l for a summary of these methods. In general, hydrocarbon components, whether of
Stoddard solvent or other hydrocarbon mixtures such as fuel oils, have relatively simple sample preparation
procedures, which consist of adsorption of the volatilehydrocarbons to an adsorption column or charcoal,
followed by elution and injection into the gas chromatograph. Capillary columns that have been successfully
used include charcoal (Pedersen et al. 1984), Chromosorb G (Astrand et al. 1975), and Porapak or Chemipak
(Kimura et al. 1988). The error associated with detecting white spirits by these methods is between 4% for
adipose-tissue (Pedersen et al. 1984) and 8.3% for air and blood (Astrand et al. 1975). Wide-bore capillary
columns have also been used (Hara et al. 1988) for GUMS analysis combined with flame ionization detectors
(FID). This method determined levels of several volatile organic compounds in the blood, urine, and






As with biological materials, detection of Stoddard solvent in environmental samples is based on the
detection of component hydrocarbons. See Table 6-2 for a summary of the analytical methods used to
determine Stoddard solvent hydrocarbons in environmental samples.
The primary method for detecting volatile components of Stoddard solvent in air is GC using a flame
ionization detector (FID) (NIOSH 1984; Otson et al. 1983). Stoddard solvent in air may be
determined by absorption to an appropriate column such as charcoal, desorption in a solvent (carbon
disulfide is recommended), and subsequent quantification.  Although the precision of this method is
good (greater than 10% relative standard deviation when the recovery is greater than 80%), in general, recovery tends
to be rather poor (18-80%) because of the slow volatilization of Stoddard solvent (Otson et al. 1983).
No analytical methods specific for Stoddard solvent in water or soil samples were located; however,
determination of Stoddard solvent may be assumed to be similar to the detection of comparable
hydrocarbon mixtures. Detection of Stoddard solvent in water is dependent on the identification and
quantification of the specific hydrocarbon components of the solvent. The primary method, GC either
alone or in combination with MS, may be used for the identification of the major hydrocarbon
components, i.e., n-alkanes, branched alkanes, cycloalkanes, and alkylbenzenes. Separation of the
aliphatic and aromatic fractions may be achieved by liquid-solid column chromatography followed by
dilution of the eluates with carbon disulfide. Aqueous samples may be extracted with
trichlorotrifluoroethane, while solid samples may be extracted by Soxhlet extraction or sonication
methods (Air Force 1989). Purgeable (volatile) aromatics may be determined with a purge-and-trap
apparatus. This method requires a trap with a Tenax/Chromosorb absorbent and the use of GC with a
photoionization detector (PID) (EPA 1991c), an ion trap detector (ITD), or FID (Thomas and Delfino
1991). A modification of the purge-and-trap method uses ambient temperature, has the advantage of
being applicable to a variety of waters, requires virtually no sample preparation (no solvents are
required for desorbing the hydrocarbons), and has an analysis time of approximately 30 minutes
(Bianchi et al. 1991). While this method may be used for determining the presence of industrial
solvent mixtures in water, it cannot distinguish between various sources of this contamination, e.g.,
gasoline, kerosene, Stoddard solvent.


 STODDARD SOLVENT 108
6. ANALYTICAL METHODS
Although no analytical methods were identified for determining the presence of Stoddard solvent in
soil samples, methods do exist for detecting other hydrocarbon mixtures, such as kerosene, and these
may be applicable to Stoddard solvent. Two methods that have been used for petroleum distillates
include GC/FID (Galin et al. 1990) and gas liquid chromatography (GLC) with FID (Midkiff and
Washington 1972). Soil samples are extracted with carbon tetrachloride. Recovery, sensitivity, and
levels of detection data were not reported. Quantification of oils and grease, by gross weight only, in
soils and sludges may be accomplished by extraction with a Soxhlet apparatus using either
trichlorotrifluoroethane (APHA 1985) or methylene chloride (Martin et al. 1991) as the solvent,
although this method is qualitative, not quantitative, and cannot be used to identify the type of oil or
grease bound to the soil.
While no analytical methods were located that are specific for detecting Stoddard solvent in sediment,
as with water and soil, methods that detect other hydrocarbon mixtures may be applicable. For
example, quantification of fuel oil hydrocarbons from sediments is a relatively involved process.
Following extraction, the saturated and olefinic hydrocarbon fraction is separated from the aromatic
hydrocarbon fraction using thin-layer chromatography or column chromatography. Fractions are
subsequently analyzed by GLC (Gearing et al. 1980).
6.3 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with
the Administrator of EPA and agencies and programs of the Public Health Service) to assess whether
adequate information on the health effects of Stoddard solvent is available. Where adequate
information is not available, ATSDR, in conjunction with NTP, is required to assure the initiation of a
program of research designed to determine the health effects (and techniques for developing methods
to determine such health effects) of Stoddard solvent.
The following categories of possible data needs have been identified by a joint team of scientists from
ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that, if met,
would reduce or eliminate the uncertainties of human health assessment. This definition should not be
interpreted to mean that all data needs discussed in this section must be filled. In the future, the




6.3.1 Identification of Data Needs
Methods for Determining Biomarkers of Exposure and Effect. There are no known methods
for determining biomarkers of exposure or effect that are specific to Stoddard solvent. Components of
white spirit have been identified in human blood, fat, and alveolar air using GC-MS. Further
information of this type, including the possible identification of a trace compound(s) for Stoddard
solvent as well as information on its metabolites in humans, would be useful for determining whether
an individual has been exposed to Stoddard solvent. It has been suggested that elevated levels of
dimethylbenzoic acid or dimethylhippuric acid, metabolites of trimethylbenzene, in the urine may be
indicative to exposure to Stoddard solvent (Fukaya et al. 1994; Pfaffli et al. 1985). Metabolites of
t-butylcyclohexane, another component of white spirits, were found in rat urine (Henningsen et al.
1987). Further studies concerning the use of these compounds as biomarkers of exposure are needed.
Methods for Determining Parent Compounds and Degradation Products in Environmental Media. Although
no specific methods were located for measuring Stoddard solvent in soil or water, methods do exist for
measuring particular hydrocarbon components of Stoddard solvent, such as 2,6-dimethyloctane, based on
analysis with GC. In addition, it may be possible to identify Stoddard solvent based on characteristic ratios
of hydrocarbon components, but such ratios have not be established. An analytical method does exist for
determining Stoddard solvent in air using GC/FID (NIOSH 1984; Otson et al. 1983). The precision of the
method is good, but recovery is poor. Some methods for detecting hydrocarbon fractions for other hydro-
carbon mixtures (e.g., gasoline, fuel oils) in environmental media may be applicable to Stoddard solvent
(Bianchi et al. 1991; Gearing et al.1980; Midkiff and Washington 1972) but should be subjected to further
analysis to determine their precision, recovery, and selectivity when used for Stoddard solvent. In addition,
methods should be developed to distinguish between contamination from Stoddard solvent versus other
petroleum distillates. At present, knowledge on the exact hydrocarbon components and their ratios in
various hydrocarbon mixtures (e.g., kerosene, Stoddard solvent, and paint thinners) is scarce, and more
precise numbers would facilitate the determination of the exact hydrocarbon mixture present in environmental
samples. This would be particularly useful for determining hydrocarbon wastes and contamination at




No on-going studies were located for Stoddard solvent.
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7. REGULATIONS AND ADVISORIES
The international, national, and state regulations and guidelines regarding Stoddard solvent in air,
water, and other media are summarized in Table 7-1.
There is no EPA reference dose (RfD) or reference concentration (RfC) for Stoddard solvent.
Stoddard solvent contains volatile organic compounds (VOC) and may be regulated under the Clean
Air Act guidelines for reduction of VOC emissions from solvents (Clean Air Act 1990).
Under the Hazardous Materials Transportation Act, Stoddard solvent is designated as a hazardous
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Acute Exposure -- Exposure to a chemical for a duration of 14 days or less, as specified in the
Toxicological Profiles.
Adsorption Coefficient (KOC) -- The ratio of the amount of a chemical adsorbed per unit weight of
organic carbon in the soil or sediment to the concentration of the chemical in solution at equilibrium.
Adsorption Ratio (Kd) -- The amount of a chemical adsorbed by a sediment or soil (i.e., the solid
phase) divided by the amount of chemical in the solution phase, which is in equilibrium with the solid
phase, at a fixed solid/solution ratio. It is generally expressed in micrograms of chemical sorbed per
gram of soil OH sediment.
Bioconcentration Factor (BCF) -- The quotient of the concentration of a chemical in aquatic
organisms at a specific time or during a discrete time period of exposure divided by the concentration
in the surrounding water at the same time or during the same period.
Cancer Effect Level (CEL) -- The lowest dose of chemical in a study, or group of studies, that
produces significant increases in the incidence of cancer (or tumors) between the exposed population
and its appropriate control.
Carcinogen -- A chemical capable of inducing cancer.
Ceiling Value -- A concentration of a substance that should not be exceeded, even instantaneously.
Chronic Exposure -- Exposure to a chemical for 365 days or more, as specified in the Toxicological
Profiles.
Developmental Toxicity -- The occurrence of adverse effects on the developing organism that may
result from exposure to a chemical prior to conception (either parent), during prenatal development, or
postnatally to the time of sexual maturation. Adverse developmental effects may be detected at any
point in the life span of the organism.
Embryotoxicity and Fetotoxicity -- Any toxic effect on the conceptus as a result of prenatal exposure
to a chemical; the distinguishing feature between the two terms is the stage of development during
which the insult occurred. The terms, as used here, include malformations and variations, altered
growth, and in utero death.
EPA Health Advisory-- An estimate of acceptable drinking water levels for a chemical substance
based on health effects information. A health advisory is not a legally enforceable federal standard,
but serves as technical guidance to assist federal, state, and local officials.
Immediately Dangerous to Life or Health (IDLH) -- The maximum environmental concentration of




Intermediate Exposure -- Exposure to a chemical for a duration of 15-364 days, as specified in the
Toxicological Profiles.
Immunologic Toxicity -- The occurrence of adverse effects on the immune system that may result
from exposure to environmental agents such as chemicals.
In Vitro -- Isolated from the living organism and artificially maintained, as in a test tube.
In Vivo -- Occurring within the living organism.
Lethal Concentration(LO)(LCLO) -- The lowest concentration of a chemical in air which has been
reported to have caused death in humans or animals.
Lethal Concentration(50)(LC50) -- A calculated concentration of a chemical in air to which exposure for a
specific length of time is expected to cause death in 50% of a defined experimental animal population.
Lethal Dose(LO) ( LDLO) -- The lowest dose of a chemical introduced by a route other than inhalation
that is expected to have caused death in humans or animals.
Lethal Dose(50) (LT50) -- The dose of a chemical which has been calculated to cause death in 50% of a
defined experimental animal population.
Lethal Time(50) (LT50) -- A calculated period of time within which a specific concentration of a
chemical is expected to cause death in 50% of a defined experimental animal population.
Lowest-Observed-Adverse-Effect Level (LOAEL) -- The lowest dose of chemical in a study, or
group of studies, that produces statistically or biologically significant increases in frequency or severity of
adverse effects between the exposed population and its appropriate control.
Malformations -- Permanent structural changes that may adversely affect survival, development, or
function.
Minimal Risk Level -- An estimate of daily human exposure to a dose of a chemical that is likely to
be without an appreciable risk of adverse noncancerous effects over a specified duration of exposure.
Mutagen -- A substance that causes mutations. A mutation is a change in the genetic material in a
body cell. Mutations can lead to birth defects, miscarriages, or cancer.
Neurotoxicity -- The occurrence of adverse effects on the nervous system following exposure to
chemical.
No-Observed-Adverse-Effect Level (NOAEL) -- The dose of chemical at which there were no
statistically or biologically significant increases in frequency or severity of adverse effects seen
between the exposed population and its appropriate control. Effects may be produced at this dose, but
they are not considered to be adverse.
Octanol-Water Partition Coefficient (KOW) -- The equilibrium ratio of the concentrations of a
chemical in n-octanol and water, in dilute solution.
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Permissible Exposure Limit (PEL) -- An allowable exposure level in workplace air averaged over an 8-hour
shift.
q1* -- The upper-bound estimate of the low-dose slope of the dose-response curve as determined by
the multistage procedure. The q1* can be used to calculate an estimate of carcinogenic potency, the
incremental excess cancer risk per unit of exposure (usually µg/L for water, mg/kg/day for food, and
µg/m3 for air).
Reference Dose (RfD) -- An estimate (with uncertainty spanning perhaps an order of magnitude) of
the daily exposure of the human population to a potential hazard that is likely to be without risk of
deleterious effects during a lifetime. The RfD is operationally derived from the NOAEL (from animal
and human studies) by a consistent application of uncertainty factors that reflect various types of data
used to estimate RfDs and an additional modifying factor, which is based on a professional judgment
of the entire database on the chemical. The RfDs are not applicable to nonthreshold effects such as
cancer.
Reportable Quantity (RfD) -- The quantity of a hazardous substance that is considered reportable
under CERCLA. Reportable quantities are (1) 1 pound or greater or (2) for selected substances, an
amount established by regulation either under CERCLA or under Sect. 311 of the Clean Water Act.
Quantities are measured over a 24-hour period.
Reproductive Toxicity -- The occurrence of adverse effects on the reproductive system that may
result from exposure to a chemical. The toxicity may be directed to the reproductive organs and/or the
related endocrine system. The manifestation of such toxicity may be noted as alterations in sexual
behavior, fertility, pregnancy outcomes, or modifications in other functions that are dependent on the
integrity of this system.
Short-Term Exposure Limit (STEL) -- The maximum concentration to which workers can be
exposed for up to 15 min continually. No more than four excursions are allowed per day, and there
must be at least 60 min between exposure periods. The daily TLV-TWA may not be exceeded.
Sister Chromatid Exchange (SCE) -- The result of DNA repair when the damaged piece of
chromosome is exchanged with the analogous piece on the corresponding sister chromatid.
Target Organ Toxicity -- This term covers a broad range of adverse effects on target organs or
physiological systems (e.g., renal, cardiovascular) extending from those arising through a single limited
exposure to those assumed over a lifetime of exposure to a chemical.
Teratogen -- A chemical that causes structural defects that affect the development of an organism.
Threshold Limit Value (TLV) -- A concentration of a substance to which most workers can be
exposed without-adverse effect. The TLV may be expressed as a TWA, as a STEL, or as a CL.
Time-Weighted Average (TWA) -- An allowable exposure concentration averaged over a normal 8-
hour workday or 40-hour workweek.
Toxic Dose (TD50) -- A calculated dose of a chemical, introduced by a route other than inhalation,
which is expected to cause a specific toxic effect in 50% of a defined experimental animal population.
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Uncertainty Factor (UF) -- A factor used in operationally deriving the RfD from experimental data.
UFs are intended to account for (1) the variation in sensitivity among the members of the human
population, (2) the uncertainty in extrapolating animal data to the case of human, (3) the uncertainty in
extrapolating from data obtained in a study that is of less than lifetime exposure, and (4) the







This chapter of the profile is a health effects summary written in non-technical language. Its intended
audience is the general public especially people living in the vicinity of a hazardous waste site or
chemical release. If the Public Health Statement were removed from the rest of the document, it
would still communicate to the lay public essential information about the chemical.
The major headings in the Public Health Statement are useful to find specific topics of concern. The
topics are written in a question and answer format. The answer to each question includes a sentence
that will direct the reader to chapters in the profile that will provide more information on the given
topic.
Chapter 2
Tables and Figures for Levels of Significant Exposure (LSE)
Tables (2-1, 2-2, and 2-3) and figures (2-l and 2-2) are used to summarize health effects and illustrate
graphically levels of exposure associated with those effects. These levels cover health effects observed
at increasing dose concentrations and durations, differences in response by species, minimal risk levels
(MRLs) to humans for noncancer endpoints, and EPA’s estimated range associated with an,
upper-bound individual lifetime cancer risk of 1 in 10,000 to 1 in 10,000,000. Use the LSE tables and
figures for a quick review of the health effects and to locate data for a specific exposure scenario. The
LSE tables and figures should always be used in conjunction with the text. All entries in these tables
and figures represent studies that provide reliable, quantitative estimates of No-Observed-Adverse-
Effect Levels (NOAELs), Lowest-Observed-Adverse-Effect Levels (LOAELs), or Cancer Effect Levels
(CELs).
The legends presented below demonstrate the application of these tables and figures. Representative
examples of LSE Table 2-l and Figure 2-l are shown. The numbers in the left column of the legends
correspond to the numbers in the example table and figure.
LEGEND
See LSE Table 2-1
1. Route of Exposure One of the first considerations when reviewing the toxicity of a substance
using these tables and figures should be the relevant and appropriate route of exposure. When
sufficient data exists, three LSE tables and two LSE figures are presented in the document. The three
LSE tables present data on the three principal routes of exposure, i.e., inhalation, oral, and dermal (LSE
Table 2-1, 2-2, and 2-3, respectively). LSE figures are limited to the inhalation (LSE Figure 2-l) and oral
(LSE Figure 2-2) routes. Not all substances will have data on each route of exposure and will not
therefore have all five of the tables and figures.
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2. Exposure Period Three exposure periods - acute (less than 15 days), intermediate (15-364 days), and
chronic (365 days or more) are presented within each relevant route of exposure. In this example, an
inhalation study of intermediate exposure duration is reported. For quick reference to health effects
occurring from a known length of exposure, locate the applicable exposure period within the LSE table
and figure.
3. Health Effect The major categories of health effects included in LSE tables and figures are
death, systemic, immunological, neurological, developmental, reproductive, and cancer.
NOAELs and LOAELs can be reported in the tables and figures for all effects but cancer.
Systemic effects are further defined in the “System” column of the LSE table (see key number
18).
4. Key to Figure Each key number in the LSE table links study information to one or more data
points using the same key number in the corresponding LSE figure. In this example, the study
represented by key number 18 has been used to derive a NOAEL and a Less Serious LOAEL
(also see the 2 ” 18r” data points in Figure 2-l).
5. Species The test species, whether animal or human, are identified in this column. Section 2.4,
“Relevance to Public Health,” covers the relevance of animal data to human toxicity and Section
2.3, “Toxicokinetics,” contains any available information on comparative toxicokinetics.
Although NOAELs and LOAELs are species specific, the levels are extrapolated to equivalent
human doses to derive an MRL.
6. Exposure Frequency/Duration The duration of the study and the weekly and daily exposure
regimen are provided in this column. This permits comparison of NOAELs and LOAELs from
different studies. In this case (key number 18), rats were exposed to toxaphene via inhalation for
6 hours per day, 5 days per week, for 3 weeks. For a more complete review of the dosing
regimen refer to the appropriate sections of the text or the original reference paper, i.e., Nitschke
et al. 1981.
7. System This column further defines the systemic effects. These systems include: respiratory,
cardiovascular, gastrointestinal, hematological, musculoskeletal, hepatic, renal, and dermal/ocular.
“Other” refers to any systemic effect (e.g., a decrease in body weight) not covered in these systems. In
the example of key number 18, 1 systemic effect (respiratory) was investigated.
8. NOAEL A No-Observed-Adverse-Effect Level (NOAEL) is the highest exposure level at which
no harmful effects were seen in the organ system studied. Key number 18 reports a NOAEL of
3 ppm for the respiratory system which was used to derive an intermediate exposure, inhalation
MRL of 0.005 ppm (see footnote “b”).
9. LOAEL A Lowest-Observed-Adverse-Effect Level (LOAEL) is the lowest dose used in the
study that caused a harmful health effect. LOAELs have been classified into “Less Serious” and
“Serious” effects. These distinctions help readers identify the levels of exposure at which
adverse health effects first appear and the gradation of effects with increasing dose. A brief
description of the specific endpoint used to quantify the adverse effect accompanies the LOAEL.
The respiratory effect reported in key number 18 (hyperplasia) is a Less serious LOAEL of 10
ppm. MRLs are not derived from Serious LOAELs.
10.  Reference The complete reference citation is given in chapter 8 of the profile.
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11. CEL A Cancer Effect Level (CEL) is the lowest exposure level associated with the onset of
carcinogenesis in experimental or epidemiologic studies. CELs are always considered serious
effects. The LSE tables and figures do not contain NOAELs for cancer, but the text may report doses not
causing measurable cancer increases.
12. Footnotes Explanations of abbreviations or reference notes for data in the LSE tables are found in the




LSE figures graphically illustrate the data presented in the corresponding LSE tables. Figures help the
reader quickly compare health effects according to exposure concentrations for particular exposure
periods.
13. Exposure Period The same exposure periods appear as in the LSE table. In this example, health effects
observed within the intermediate and chronic exposure periods are illustrated.
14. Health Effect These are the categories of health effects for which reliable quantitative data
exists. The same health effects appear in the LSE table.
15. Levels of Exposure concentrations or doses for each health effect in the LSE tables are
graphically displayed in the LSE figures. Exposure concentration or dose is measured on the log scale
“y” axis. Inhalation exposure is reported in mg/m’ or ppm and oral exposure is reported in mg/kg/day .
16. NOAEL In this example, 18r NOAEL is the critical endpoint for which an intermediate
inhalation exposure MRL is based. As you can see from the LSE figure key, the open-circle
symbol indicates to a NOAEL for the test species-rat. The key number 18 corresponds to the
entry in the LSE table. The dashed descending arrow indicates the extrapolation from the
exposure level of 3 ppm (see entry 18 in the Table) to the MRL of 0.005 ppm (see footnote “b” in the
LSE table).
17. CEL Key number 38r is 1 of 3 studies for which Cancer Effect Levels were derived. The
diamond symbol refers to a Cancer Effect Level for the test species-mouse. The number 38
corresponds to the entry in the LSE table.
18. Estimated Upper-Bound Human Cancer Risk Levels This is the range associated with the
upper-bound for lifetime cancer risk of 1 in 10,000 to 1 in 10,000,000. These risk levels are
derived from the EPA’s Human Health Assessment Group’s upper-bound estimates’of the slope of the
cancer dose response curve at low dose levels (q1*).





Chapter 2 (Section 2.4)
Relevance to Public Health
The Relevance to Public Health section provides a health effects summary based on evaluations of
existing toxicologic, epidemiologic, and toxicokinetic information. This summary is designed to
present interpretive, weight-of-evidence discussions for human health endpoints by addressing the
following questions.
     1. What effects are known to occur in humans?
     2. What effects observed in animals are likely to be of concern to humans?
     3. What exposure conditions are likely to be of concern to humans, especially around hazardous
          waste sites?
The section covers endpoints in the same order they appear within the Discussion of Health Effects by
Route of Exposure section, by route (inhalation, oral, dermal) and within route by effect. Human data
are presented first, then animal data. Both are organized by duration (acute, intermediate, chronic). In
vitro data and data from parenteral routes (intramuscular, intravenous, subcutaneous, etc.) are also
considered in this section. If data are located in the scientific literature, a table of genotoxicity
information is included.
The carcinogenic potential of the profiled substance is qualitatively evaluated, when appropriate, using
existing toxicokinetic, genotoxic, and carcinogenic data. ATSDR does not currently assess cancer potency or
perform cancer risk assessments. Minimal risk levels (MRLs) for noncancer endpoints (if derived) and the
endpoints from which they were derived are indicated and discussed.
Limitations to existing scientific literature that prevent a satisfactov evaluation of the relevance to
public health are identified in the Data Needs section.
Interpretation of Minimal Risk Levels
Where sufficient toxicologic information is available, we have derived minimal risk levels (MRLs) for
inhalation and oral routes of entry at each duration of exposure (acute, intermediate, and chronic).
These MRLs are not meant to support regulatory action; but to acquaint health professionals with
exposure levels at which adverse health effects are not expected to occur in humans. They should
help physicians and public health officials determine the safety of a community living near a chemical
emission, given the concentration of a contaminant in air or the estimated daily dose in water. MRLs
are based largely on toxicological studies in animals and on reports of human occupational exposure.
MRL users should tie familiar with the toxicologic information on which the number is based.
Chapter 2.4, “Relevance to Public Health,” contains basic information known about the substance.
Other sections such as 2.6, “Interactions with Other Substances,” and 2.7, “Populations that are
Unusually Susceptible” provide important supplemental information.
MRL users should also understand the MRL derivation methodology. MRLs are derived using a
modified version of the risk assessment methodology the Environmental Protection Agency (EPA)
provides (Barnes and Dourson 1988) to determine reference doses for lifetime exposure (RfDs).
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To derive an MRL, ATSDR generally selects the most sensitive endpoint which, in its best judgement,
represents the most sensitive human health effect for a given exposure route and duration. ATSDR
cannot make this judgement or derive an MRL unless information (quantitative or qualitative) is
available for all potential systemic, neurological, and developmental effects. If this information and
reliable quantitative data on the chosen endpoint are available, ATSDR derives an MRL using the
most sensitive species (when information from multiple species is available) with the highest NOAEL
that does not exceed any adverse effect levels. When a NOAEL is not available, a
lowest-observed-adverse-effect level (LOAEL) can be used to derive an MRL, and an uncertainty
factor (UF) of 10 must be employed. Additional uncertainty factors of 10 must be used both for
human variability to protect sensitive subpopulations (people who are most susceptible to the health
effects caused by the substance) and for interspecies variability (extrapolation from animals to
humans). In deriving an MRL, these individual uncertainty factors are multiplied together. The
product is then divided into the inhalation concentration or oral dosage selected from the study.
Uncertainty factors used in developing a substance-specific MRL are provided in the footnotes of the
LSE Tables.




